JP2002338549A - Benzimidazole compound, azobenzimidazole compound and its chelate compound - Google Patents
Benzimidazole compound, azobenzimidazole compound and its chelate compoundInfo
- Publication number
- JP2002338549A JP2002338549A JP2001188869A JP2001188869A JP2002338549A JP 2002338549 A JP2002338549 A JP 2002338549A JP 2001188869 A JP2001188869 A JP 2001188869A JP 2001188869 A JP2001188869 A JP 2001188869A JP 2002338549 A JP2002338549 A JP 2002338549A
- Authority
- JP
- Japan
- Prior art keywords
- group
- substituted
- unsubstituted
- ring
- alkyl group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Plural Heterocyclic Compounds (AREA)
Abstract
Description
【0001】[0001]
【発明の属する技術分野】本発明は、新規なベンズイミ
ダゾール化合物、アゾベンズイミダゾール化合物、およ
びその金属キレート化合物に関するものである。本発明
のベンズイミダゾール化合物は色素合成の中間体として
有用であり、それから導かれるアゾベンズイミダゾール
化合物及びその金属キレート化合物は色素として、繊維
用染料、プラスチック着色剤、光記録用色素、熱転写記
録用色素、カラーフィルター用色素等として利用可能な
ものである。The present invention relates to a novel benzimidazole compound, an azobenzimidazole compound and a metal chelate compound thereof. The benzimidazole compound of the present invention is useful as an intermediate in dye synthesis, and the azobenzimidazole compound and its metal chelate compound derived therefrom are dyes for fibers, dyes for plastics, dyes for optical recording, dyes for thermal transfer recording. Which can be used as colorants for color filters and the like.
【0002】[0002]
【従来の技術】アゾ化合物は色素としてさまざまな用途
で使われており、分子構造も多数のものが知られている
が、その中で有機溶剤に可溶のものは分散染料、熱転写
記録用色素、光記録用色素等として利用されている。こ
れらの色素に必要なのは、高い吸光係数、光や高温高湿
度に対する高い安定性、水に対する不溶性、有機溶剤に
対する可溶性などである。さらに、光記録用色素とくに
追記型光記録用色素としては、それらの特性に加えて、
加熱によって瞬時に構造変化が起きるといった、高い熱
応答性も求められる。そういった多岐にわたる要求を同
時に満たす既存の色素はなかなかないのが実状である。2. Description of the Related Art Azo compounds are used in various applications as dyes and have a large number of molecular structures. Among them, those soluble in organic solvents include disperse dyes and dyes for thermal transfer recording. Are used as dyes for optical recording. These dyes require high extinction coefficient, high stability to light, high temperature and high humidity, insolubility in water, and solubility in organic solvents. Furthermore, as a dye for optical recording, especially as a write-once type optical recording dye, in addition to their properties,
High thermal responsiveness, such as a structural change that occurs instantaneously due to heating, is also required. In fact, there are few existing dyes that satisfy such diverse requirements at the same time.
【0003】[0003]
【発明が解決しようとする態題】本発明者らは、上記の
ような多様な要求に応えうる色素の開発をめざして検討
を進めた結果、特定の中間物から導かれるアゾ色素及び
その金属キレート錯体がそのような有用な性質を持つこ
とを見出した。SUMMARY OF THE INVENTION The inventors of the present invention have studied to develop a dye capable of meeting the above-mentioned various requirements, and as a result, have found that an azo dye derived from a specific intermediate and its metal It has been found that chelate complexes have such useful properties.
【0004】[0004]
【課題を解決するための手段】即ち、本発明は第一に、
下記一般式(1−a)又は(1−b)で表されるベンズ
イミダゾール化合物に係るものである。That is, the present invention firstly provides:
It relates to a benzimidazole compound represented by the following general formula (1-a) or (1-b).
【0005】[0005]
【化3】 [式中、R1、R2は水素原子、アルキル基、アルコキ
シアルキル基、シアノアルキル基、アリールアルキル
基、アリール基を表す。R1とR2は同時に水素原子に
はならない。R1とR2はこれらが結合している窒素原
子と複素環を形成していてもよい。R3は水素原子、ア
ルキル基、フッ化アルキル基、置換または非置換のアリ
ール基を表す。R4は水素原子、置換または非置換のア
ルキル基、置換または非置換のアリール基を表す。R
5、R6は水素原子、アルキル基、フッ化アルキル基、
アルコキシ基、ハロゲン原子を表す]。Embedded image [Wherein, R1 and R2 represent a hydrogen atom, an alkyl group, an alkoxyalkyl group, a cyanoalkyl group, an arylalkyl group, or an aryl group. R1 and R2 do not simultaneously become hydrogen atoms. R1 and R2 may form a heterocyclic ring with the nitrogen atom to which they are bonded. R3 represents a hydrogen atom, an alkyl group, a fluorinated alkyl group, or a substituted or unsubstituted aryl group. R4 represents a hydrogen atom, a substituted or unsubstituted alkyl group, or a substituted or unsubstituted aryl group. R
5, R6 is a hydrogen atom, an alkyl group, a fluorinated alkyl group,
Represents an alkoxy group or a halogen atom].
【0006】本発明は第二に、下記一般式(2−a)ま
たは(2−b)で表されるアゾベンズイミダゾール化合
物に係るものである。The present invention secondly relates to an azobenzimidazole compound represented by the following general formula (2-a) or (2-b).
【0007】[0007]
【化4】 [式中、R1、R2、R3、R4、R5、R6は前記と
同様であり、Xは置換または非置換の芳香環、置換また
は非置換の複素環を表す]。Embedded image [Wherein, R1, R2, R3, R4, R5, and R6 are the same as described above, and X represents a substituted or unsubstituted aromatic ring or a substituted or unsubstituted heterocyclic ring].
【0008】本発明は第三に、上記に記載のアゾベンズ
イミダゾール化合物と2価金属イオンとのキレート化合
物および上記に記載のアゾベンズイミダゾール化合物と
3価金属イオンとのキレート化合物に係るものである。The present invention thirdly relates to a chelate compound of the above-mentioned azobenzimidazole compound with a divalent metal ion and a chelate compound of the above-mentioned azobenzimidazole compound with a trivalent metal ion. .
【0009】前記した本発明の化合物は、ベンズイミダ
ゾール骨格の4位または7位にアルキルアミノ基をもつ
ことを特徴とする。このアルキルアミノ基のパラ位にア
ゾ基を導入した化合物は、アルキルアミノ基からアゾ基
の方向への電子移動により、吸光係数の大きな色素とな
る。さらにその分子構造において、ベンズイミダゾール
骨格に含まれる窒素とアゾ基を構成する窒素は金属イオ
ンをキレート化するのに都合の良い位置関係にあるの
で、安定なキレート錯体の形成が可能になる。こうして
得られる含金属アゾ色素は高い吸光係数と、含金属色素
特有の高い耐候性を持ち、また本来親油性の低い金属成
分が親油性の高い有機色素成分によって取り囲まれてい
るため、有機溶剤に対する親和性も高いものとなる。The above-mentioned compound of the present invention is characterized by having an alkylamino group at the 4- or 7-position of the benzimidazole skeleton. The compound having an azo group introduced at the para-position of the alkylamino group becomes a dye having a large absorption coefficient due to electron transfer from the alkylamino group to the azo group. Further, in the molecular structure, the nitrogen contained in the benzimidazole skeleton and the nitrogen constituting the azo group are in a convenient positional relationship for chelating a metal ion, so that a stable chelate complex can be formed. The metal-containing azo dye thus obtained has a high extinction coefficient and a high weather resistance characteristic of the metal-containing dye, and the metal component originally having low lipophilicity is surrounded by the organic dye component having high lipophilicity. The affinity is also high.
【0010】これらの一般式(1−a)と(1−b)、
および(2−a)と(2−b)はそれぞれ異性体を表し
ているが、R4が水素原子である場合には、それらはそ
れぞれ互変異性体となるので、互いを分離することは通
常不可能であり、実質的に同一物として扱われる。以下
の記述においても、どちらか一方の構造を表示して両方
を示すことがある。These general formulas (1-a) and (1-b)
And (2-a) and (2-b) represent isomers, respectively. When R4 is a hydrogen atom, they are each a tautomer, so that it is usual to separate them from each other. Impossible and treated as substantially the same. In the following description, one of the structures may be displayed to indicate both.
【0011】[0011]
【発明の実施の形態】一般式(1−a)、(1−b)、
(2−a)、(2−b)の化合物におけるR1、R2の
例としては後述の実施例にみられる様な低級アルキル
基、R1とR2とがこれらに結合している窒素原子とピ
ロリジン環もしくはピペリジン環を形成したものなどが
ある。同様に、R3の例としては、水素原子、フッ素原
子で置換されていてもよい低級アルキル基、未置換のフ
ェニル基などがあり、R4、R5、R6の例としては水
素原子、低級アルキル基などがある。ここで低級アルキ
ル基とは、C1〜C3のアルキル基をいう。Xの例とし
ては、後述の実施例にみられる様な置換および非置換の
ピリジン環、置換および非置換のピリミジン環、置換お
よび非置換のピリダジン環、置換および非置換のピラジ
ン環、置換および非置換のキノリン環、置換および非置
換のピラゾール環、置換および非置換のチアゾール環、
置換および非置換のチアジアゾール環、置換および非置
換のオキサゾール環、置換および非置換のイソキサゾー
ル環、置換および非置換のトリアゾール環、及び置換お
よび非置換のベンゾチアゾール環から選ばれる複素環で
あって、この複素環が置換基を有するものである場合、
置換基がメチル基、トリフルオロメチル基、塩素原子及
びフェニル基から成る群から選択されたものがある。同
様に、金属イオンの例としては、ニッケル、銅、亜鉛、
マンガン等の2価の金属イオン、アルミニウム、クロ
ム、鉄、コバルト等の3価の金属イオンがある。BEST MODE FOR CARRYING OUT THE INVENTION The general formulas (1-a), (1-b),
Examples of R1 and R2 in the compounds of (2-a) and (2-b) include a lower alkyl group as shown in Examples described later, a nitrogen atom having R1 and R2 bonded thereto, and a pyrrolidine ring. Alternatively, those having a piperidine ring may be used. Similarly, examples of R3 include a hydrogen atom, a lower alkyl group which may be substituted with a fluorine atom, and an unsubstituted phenyl group. Examples of R4, R5 and R6 include a hydrogen atom, a lower alkyl group and the like. There is. Here, the lower alkyl group refers to a C1-C3 alkyl group. Examples of X include substituted and unsubstituted pyridine rings, substituted and unsubstituted pyrimidine rings, substituted and unsubstituted pyridazine rings, substituted and unsubstituted pyrazine rings, substituted and unsubstituted Substituted quinoline ring, substituted and unsubstituted pyrazole ring, substituted and unsubstituted thiazole ring,
A substituted and unsubstituted thiadiazole ring, a substituted and unsubstituted oxazole ring, a substituted and unsubstituted isoxazole ring, a substituted and unsubstituted triazole ring, and a heterocyclic ring selected from substituted and unsubstituted benzothiazole rings, When the heterocyclic ring has a substituent,
Some substituents are selected from the group consisting of a methyl group, a trifluoromethyl group, a chlorine atom and a phenyl group. Similarly, examples of metal ions include nickel, copper, zinc,
There are divalent metal ions such as manganese and trivalent metal ions such as aluminum, chromium, iron and cobalt.
【0012】上記以外の、R1、R2の例としては、C
4〜C12の直鎖もしくは分岐のアルキル基、置換基を
有していてもよいベンジル基、メトキシエチル基、エト
キシエチル基、メトキシプロピル基、エトキシプロピル
基、ブトキシエチル基、2−シアノエチル基、3−シア
ノプロピル基、4−シアノブチル基などがある。またR
1とR2がこれらに結合している窒素原子とともに形成
した複素環の例として、モルホリン環などがある。同様
に前記以外のR3の例としては、C4〜C12の直鎖ま
たは分岐のアルキル基、トリル基、ジメチルフェニル
基、トリメチルフェニル基、t−ブチルフェニル基、ク
ロロフェニル基、ブロモフェニル基、フルオロフェニル
基、トリフルオロメチルフェニル基、ニトロフェニル
基、ナフチル基などがあり、またR4の例としては、C
4〜C12の直鎖もしくは分岐のアルキル基などが、R
5、R6の例としては、トリフルオロメチル基、メトキ
シ基、エトキシ基、フッ素原子、塩素原子、臭素原子、
ヨウ素原子などがある。Other examples of R1 and R2 other than the above include C
4-C12 linear or branched alkyl group, optionally substituted benzyl group, methoxyethyl group, ethoxyethyl group, methoxypropyl group, ethoxypropyl group, butoxyethyl group, 2-cyanoethyl group, 3 -Cyanopropyl group, 4-cyanobutyl group and the like. Also R
Examples of the heterocyclic ring formed by 1 and R2 together with the nitrogen atom bonded thereto include a morpholine ring. Similarly, examples of R3 other than the above include C4-C12 linear or branched alkyl, tolyl, dimethylphenyl, trimethylphenyl, t-butylphenyl, chlorophenyl, bromophenyl, and fluorophenyl groups. , A trifluoromethylphenyl group, a nitrophenyl group, a naphthyl group, and the like.
A linear or branched alkyl group of 4 to C12 is represented by R
5, examples of R6 include a trifluoromethyl group, a methoxy group, an ethoxy group, a fluorine atom, a chlorine atom, a bromine atom,
And iodine atoms.
【0013】さらに前記以外のXの例としては、置換お
よび非置換のベンゼン環、置換および非置換のナフタレ
ン環、置換および非置換のフェナントレン環、置換およ
び非置換のトリアジン環、置換および非置換のキナゾリ
ン環、置換および非置換のフタラジン環、置換および非
置換のイミダゾール環、置換および非置換のオキサゾー
ル環、置換および非置換のテトラゾール環、置換および
非置換のベンズイミダゾール環、置換および非置換のイ
ンダゾール環、置換および非置換のベンゾトリアゾール
環等がある。Xの置換基の例としては、前記以外にエチ
ル基、プロピル基、ブチル基、ニトロ基、シアノ基、置
換基を有するフェニル基、ピリジル基、メトキシ基、エ
トキシ基、プロポキシ基、ブトキシ基、トリフルオロエ
トキシ基、置換基を有していてもよいフェノキシ基、置
換基を有していてもよいフェニルチオ基、フッ素原子、
塩素原子、臭素原子、ヨウ素原子、ヒドロキシ基、カル
ボキシ基、スルホン酸基等がある。Examples of X other than the above include substituted and unsubstituted benzene rings, substituted and unsubstituted naphthalene rings, substituted and unsubstituted phenanthrene rings, substituted and unsubstituted triazine rings, substituted and unsubstituted triazine rings. Quinazoline ring, substituted and unsubstituted phthalazine ring, substituted and unsubstituted imidazole ring, substituted and unsubstituted oxazole ring, substituted and unsubstituted tetrazole ring, substituted and unsubstituted benzimidazole ring, substituted and unsubstituted indazole And substituted and unsubstituted benzotriazole rings. Examples of the substituent of X include, in addition to the above, an ethyl group, a propyl group, a butyl group, a nitro group, a cyano group, a phenyl group having a substituent, a pyridyl group, a methoxy group, an ethoxy group, a propoxy group, a butoxy group, and a trioxy group. Fluoroethoxy group, a phenoxy group which may have a substituent, a phenylthio group which may have a substituent, a fluorine atom,
Examples include a chlorine atom, a bromine atom, an iodine atom, a hydroxy group, a carboxy group, and a sulfonic acid group.
【0014】本発明の一般式(1−a)、(1−b)の
ベンズイミダゾール化合物は下記するスキームに示す工
程で合成することができる。The benzimidazole compounds of the general formulas (1-a) and (1-b) of the present invention can be synthesized by the steps shown in the following scheme.
【0015】[0015]
【化5】 [式中Lはアシル基またはスルホニル基を表す]。Embedded image [Wherein L represents an acyl group or a sulfonyl group].
【0016】[0016]
【化6】 [式中Lは、スキーム1の場合と同様の置換基を表
す]。Embedded image [Wherein L represents the same substituent as in Scheme 1].
【0017】[0017]
【化7】 スキーム3Embedded image Scheme 3
【0018】スキーム1においてr1は、アミノ基の保
護基として置換基Lを導入する反応であり、反応剤とし
てはカルボン酸無水物、ハロゲン化アシル、スルホン酸
無水物、ハロゲン化スルホニル等を使うことができる。
r2のニトロ化反応には硝酸、発煙硝酸、混酸などを使
うことができる。このときニトロ化が目的の位置に選択
的に起こるかどうかが問題であるが、たとえばJACS
(Journal of the American
Chemical Society),vol.63,
p.3276−3278(1941)、JCS(Jou
rnal ofthe Chemical Socie
ty),p.1897−1899(1955)等に記載
の合成法と同様の方法を用いれば、目的のニトロ化合物
を主成分として得ることができる。r3においてニトロ
基をアルキルアミノ基に置換する反応では一級または二
級アミノ化合物を使うことができる。r4における保護
基Lの脱離には水酸化ナトリウム、水酸化カリウム、塩
酸、硫酸などの一般的な塩基や酸を使うことができる。
ただし特別にこの工程を設けなくても、次のr5または
r6の反応のときに保護基の脱離も同時に起こさせるこ
とも可能である。r5の還元反応は、金属触媒を用いた
接触水素化や、硫化ナトリウム、亜鉛、鉄、塩化第一ス
ズなどの還元剤によって行われる。r6の環化反応には
カルボン酸、カルボン酸無水物、カルボン酸ハロゲン化
物などを用いることができる。r4〜r6の反応は中間
物を単離せず一浴で行うことも可能である。In the scheme 1, r1 is a reaction for introducing a substituent L as a protecting group for an amino group, and a carboxylic anhydride, an acyl halide, a sulfonic anhydride, a sulfonyl halide or the like is used as a reactant. Can be.
For the nitration reaction of r2, nitric acid, fuming nitric acid, mixed acid and the like can be used. At this time, it is a problem whether nitration occurs selectively at a target position.
(Journal of the American
Chemical Society), vol. 63,
p. 3276-3278 (1941), JCS (Jou
rnal of the Chemical Society
ty), p. By using a method similar to the synthesis method described in 1897-1899 (1955) and the like, a target nitro compound can be obtained as a main component. In the reaction for substituting a nitro group with an alkylamino group in r3, a primary or secondary amino compound can be used. A common base or acid such as sodium hydroxide, potassium hydroxide, hydrochloric acid, and sulfuric acid can be used for elimination of the protecting group L at r4.
However, even if this step is not particularly provided, it is possible to simultaneously remove the protecting group in the next reaction of r5 or r6. The reduction reaction of r5 is carried out by catalytic hydrogenation using a metal catalyst or a reducing agent such as sodium sulfide, zinc, iron, stannous chloride and the like. For the cyclization reaction of r6, carboxylic acid, carboxylic anhydride, carboxylic acid halide and the like can be used. The reaction of r4 to r6 can be performed in one bath without isolating the intermediate.
【0019】スキーム2におけるs1、s2は、スキー
ム1におけるr1,r2と同様の反応であり、s1の反
応にはr1と同様の反応剤を用いることができ、s2の
反応にはr2と同様の反応剤を用いることができる。ス
キーム2におけるs3の反応は、スキーム1におけるr
4と同様の反応でありr4と同様の反応剤が用いられ
る。s4はアルキル化またはアリール化反応であり、ハ
ロゲン化アルキル、ハロゲン化アリール、硫酸エステ
ル、スルホン酸エステルなどが用いられる。このアルキ
ル化、アリール化のときに、複数のアルキル化剤、アリ
ール化剤を用いることで、R1、R2が互いに異なるも
のを得ることも可能であり、またR1、R2のいずれか
を水素原子のまま残すことも可能である。スキーム2に
おけるs5、s6は、スキーム1におけるr5、r6と
同様の反応であり、r5、r6と同様の反応剤を使うこ
とができる。S1 and s2 in Scheme 2 are the same as r1 and r2 in Scheme 1, and the same reagents as r1 can be used for the reaction of s1, and the same reagents as r2 for the reaction of s2. Reactants can be used. The reaction of s3 in Scheme 2 corresponds to r in Scheme 1.
The reaction is the same as that of r4, and the same reactant as r4 is used. s4 is an alkylation or arylation reaction, in which an alkyl halide, an aryl halide, a sulfate, a sulfonate, or the like is used. By using a plurality of alkylating agents and arylating agents at the time of this alkylation and arylation, it is possible to obtain a compound in which R1 and R2 are different from each other. It is also possible to leave it as it is. S5 and s6 in Scheme 2 are the same reactions as r5 and r6 in Scheme 1, and the same reactants as r5 and r6 can be used.
【0020】スキーム3において、t1のニトロ化反応
には硝酸、混酸、発煙硝酸などを使うことができる。t
2の還元反応は接触水素化や硫化ナトリウム、亜鉛、
鉄、塩化第一スズなどで行われる。t3のアルキル化も
しくはアリール化には、ハロゲン化アルキル、ハロゲン
化アリール、硫酸エステル、スルホン酸エステルなどが
用いられる。t3のアルキル化、アリール化のときに、
複数のアルキル化剤、アリール化剤を用いることで、R
1、R2、R4が互いに異なるものを得ることも可能で
あり、またR1、R2、R4のいずれかを水素原子のま
ま残すことも可能である。In Scheme 3, nitric acid, mixed acid, fuming nitric acid and the like can be used for the nitration reaction at t1. t
2 reduction reaction is catalytic hydrogenation and sodium sulfide, zinc,
Performed with iron, stannous chloride, etc. For alkylation or arylation of t3, an alkyl halide, an aryl halide, a sulfate, a sulfonate, or the like is used. When alkylating or arylating t3,
By using a plurality of alkylating agents and arylating agents, R
It is also possible to obtain one in which 1, R2 and R4 are different from each other, and it is also possible to leave any one of R1, R2 and R4 as a hydrogen atom.
【0021】得られた一般式(1−a)、(1−b)の
化合物はアミノ化合物もしくはヒドラジノ化合物とカッ
プリング反応させることにより容易に一般式(2−
a)、(2−b)のアゾ化合物とすることができる。こ
のときアミノ化合物はジアゾ化させた上でカップリング
させるが、ジアゾ化剤として、亜硝酸ナトリウム、ニト
ロシル硫酸、亜硝酸アルキル等を用いることができる。
ヒドラジノ化合物は酸化した上でカップリングさせる
が、酸化剤としては過酸化水素、酢酸、ヨウ素、硫酸
鉄、フェリシアン化カリウム等を用いることができる。
カップリング反応に用いる溶媒はとくに限定されるもの
ではないが、水、メタノール、エタノール、プロパノー
ル、酢酸、ジメチルホルムアミド、ジメチルアセトアミ
ド、N−メチルピロリドン、N−メチルホルムアニリ
ド、ジエチルエーテル、テトラヒドロフラン、ジオキサ
ン、エチレングリコール、ジエチレングリコールジメチ
ルエーテル、ジエチレングリコールモノメチルエーテ
ル、ピリジンなどの極性溶媒が適当であり、これらは混
合して用いてもよい。また反応時のpH調整用に塩酸、
硫酸、蟻酸、水酸化ナトリウム、酢酸ナトリウム、炭酸
ナトリウム、炭酸水素ナトリウム、ナトリウムエチラー
ト、ナトリウムメチラート、カリウムブトキシド、トリ
エチルアミンなどの酸性または塩基性物質を使用した
り、炭酸ガスやアンモニアガスを吹き込んだりしてもよ
い。The resulting compounds of the general formulas (1-a) and (1-b) can be easily subjected to a coupling reaction with an amino compound or a hydrazino compound to easily form the compound of the general formula (2-a).
a) and (2-b) azo compounds. At this time, the amino compound is diazotized and then coupled. As the diazotizing agent, sodium nitrite, nitrosylsulfuric acid, alkyl nitrite and the like can be used.
The hydrazino compound is oxidized and then coupled, and as the oxidizing agent, hydrogen peroxide, acetic acid, iodine, iron sulfate, potassium ferricyanide, or the like can be used.
Although the solvent used for the coupling reaction is not particularly limited, water, methanol, ethanol, propanol, acetic acid, dimethylformamide, dimethylacetamide, N-methylpyrrolidone, N-methylformanilide, diethyl ether, tetrahydrofuran, dioxane, Polar solvents such as ethylene glycol, diethylene glycol dimethyl ether, diethylene glycol monomethyl ether, and pyridine are suitable, and these may be used as a mixture. Hydrochloric acid for pH adjustment during the reaction,
Use acidic or basic substances such as sulfuric acid, formic acid, sodium hydroxide, sodium acetate, sodium carbonate, sodium bicarbonate, sodium ethylate, sodium methylate, potassium butoxide, triethylamine, or blow carbon dioxide or ammonia gas. May be.
【0021】こうして得られた一般式(2−a)、(2
−b)のアゾ化合物は、このまま色素として使うことも
可能である。置換基の種類を変えることで橙、赤、青、
紫、緑等様々な色相の色素を得ることができる。それら
は有機溶剤に溶けやすいので、分散染料、熱転写記録用
色素等として好適である。また、それを更に金属錯体化
して使用することも可能であり、金属錯体化は一般式
(2−a)、(2−b)の化合物と金属塩とを有機溶媒
や水溶媒中で混合することにより容易に行うことができ
る。金属イオンは2価〜4価のものを用いることがで
き、配位子と金属イオンだけで電荷が中和したタイプの
キレート化合物を作ることもできるし、余剰の電荷を別
のカウンターイオンによって中和したような錯塩タイプ
のキレート化合物を作ることもできる。これらの含金属
色素も種々の有機溶剤によく溶けるので、記録材料等と
して利用が容易である。The thus obtained general formulas (2-a) and (2)
The azo compound of -b) can be used as a dye as it is. By changing the type of substituent, orange, red, blue,
Dyes of various hues such as purple and green can be obtained. Since they are easily soluble in organic solvents, they are suitable as disperse dyes, dyes for thermal transfer recording, and the like. It is also possible to use it after further forming a metal complex, and the metal complex is formed by mixing the compounds of the general formulas (2-a) and (2-b) with a metal salt in an organic solvent or an aqueous solvent. This can be easily performed. As the metal ion, a divalent to tetravalent metal ion can be used, and a chelate compound in which the charge is neutralized only by the ligand and the metal ion can be produced. Complex salt type chelate compounds can be prepared. Since these metal-containing dyes are also well soluble in various organic solvents, they can be easily used as recording materials and the like.
【0022】[0022]
【実施例】以下、本発明を実施例により更に具体的に説
明する。なお以下の説明において、ベンズイミダゾール
骨格のNに水素原子がついた化合物の場合、前記したよ
うに互変異性構造が存在するが、簡便のため、その一方
の構造を表記して両方の構造を表すものとする。すなわ
ち、置換基NR1R2の位置がベンズイミダゾールの4
位となる構造のみ表記していても、それが7位となる構
造をも表すものとする。EXAMPLES Hereinafter, the present invention will be described more specifically with reference to examples. In the following description, in the case of a compound in which a hydrogen atom is attached to N of the benzimidazole skeleton, a tautomeric structure exists as described above, but for simplicity, one of the structures is described and both structures are described. Shall be represented. That is, the position of the substituent NR1R2 is the position of 4 of benzimidazole.
Even if only the structure at the 7th position is described, it also indicates the structure at the 7th position.
【0023】A.一般式(1−a)、(1−b)の化合
物の合成 実施例A−1A. Synthesis of Compounds of General Formulas (1-a) and (1-b) Example A-1
【0024】2−メチル−4−(ジメチルアミノ)ベン
ズイミダゾールの合成 1)2,3−ジニトロアセトアニリド 反応フラスコに98%硫酸176mlを仕込み−2℃ま
で冷却した。そこへ3−ニトロアセトアニリド50gを
発煙硝酸176mlに溶解したものを、−2℃〜3℃の
温度で2時間かけて滴下した。滴下後40分間攪拌して
から氷水600mlに排出し、しばらく攪拌して析出し
た結晶を濾取、水洗した。得られた結晶をエタノールか
ら再結晶して18.3gの目的物結晶を得た。GC/M
Sにより分子量(225)を確認した。この結晶の融点
は190℃であった。また、1H−NMRの結果は次の
ようであった。1H−NMR(DMSO−d6,300
MHz):δ(from TMS)=2.08(3H,
s),7.85(1H,t,J=8.2Hz),7.9
7(1H,dd,J=1.3Hz,8.2Hz)8.0
4(1H,dd,J=1.3Hz,8.2Hz),1
0.25(1H,s)。Synthesis of 2-methyl-4- (dimethylamino) benzimidazole 1) 2,3-dinitroacetanilide A reaction flask was charged with 176 ml of 98% sulfuric acid and cooled to -2 ° C. A solution obtained by dissolving 50 g of 3-nitroacetanilide in 176 ml of fuming nitric acid was added dropwise thereto at a temperature of -2 ° C to 3 ° C over 2 hours. After stirring for 40 minutes after dropping, the mixture was discharged into 600 ml of ice water, stirred for a while, and the precipitated crystals were collected by filtration and washed with water. The obtained crystal was recrystallized from ethanol to obtain 18.3 g of the target crystal. GC / M
The molecular weight (225) was confirmed by S. The melting point of this crystal was 190 ° C. The results of 1H-NMR were as follows. 1H-NMR (DMSO-d6,300
MHz): δ (from TMS) = 2.08 (3H,
s), 7.85 (1H, t, J = 8.2 Hz), 7.9
7 (1H, dd, J = 1.3 Hz, 8.2 Hz) 8.0
4 (1H, dd, J = 1.3 Hz, 8.2 Hz), 1
0.25 (1H, s).
【0025】2)3−(ジメチルアミノ)−2−ニトロ
アセトアニリド 反応フラスコ内で、1)で得た2,3−ジニトロアセト
アニリド18.3gをエタノール81ml中に懸濁さ
せ、撹拌した。そこへ50%ジメチルアミン水溶液81
mlを加えて加熱し65℃で40分間撹拌した後70℃
の温水を加え攪拌しながら放冷した。析出した結晶を濾
取しトルエンとヘキサンの混合溶媒で洗浄した。収量は
9.2gであった。GC/MSにより分子量(223)
を確認した。この結晶の融点は126℃であった。2) 3- (Dimethylamino) -2-nitroacetanilide In a reaction flask, 18.3 g of 2,3-dinitroacetanilide obtained in 1) was suspended in 81 ml of ethanol and stirred. There 50% dimethylamine aqueous solution 81
After heating and stirring at 65 ° C for 40 minutes, 70 ° C
Of warm water was added and the mixture was allowed to cool while stirring. The precipitated crystals were collected by filtration and washed with a mixed solvent of toluene and hexane. The yield was 9.2 g. Molecular weight (223) by GC / MS
It was confirmed. The melting point of the crystal was 126 ° C.
【0026】3)3−(ジメチルアミノ)−2−ニトロ
アニリン 反応フラスコ内で、2)で得た3−(ジメチルアミノ)
−2−ニトロアセトアニリド7.4gをエタノール83
ml中に懸濁させ、撹拌した。そこへ48%水酸化ナト
リウム水溶液41mlを入れ加熱した。70℃で4時間
撹拌した後、放冷し水170mlを加えクロロホルム5
00mlで抽出した。クロロホルム層を2回水洗した
後、無水硫酸ナトリウムで脱水し、硫酸ナトリウムを濾
別後、クロロホルムを留去した。収量は7.6gであっ
た。3) 3- (Dimethylamino) -2-nitroaniline 3- (dimethylamino) obtained in 2) in a reaction flask
7.4 g of 2-nitroacetanilide in ethanol 83
and stirred. 41 ml of a 48% sodium hydroxide aqueous solution was put therein and heated. After stirring at 70 ° C for 4 hours, the mixture was allowed to cool, 170 ml of water was added, and chloroform 5 was added.
Extracted with 00 ml. The chloroform layer was washed twice with water, dried over anhydrous sodium sulfate, filtered off sodium sulfate, and distilled off chloroform. The yield was 7.6 g.
【0027】4)2−メチル−4−(ジメチルアミノ)
ベンズイミダゾール 反応フラスコ内で、3)で得た3−(ジメチルアミノ)
−2−ニトロアニリン1.25gをエタノール20ml
に溶解させた。そこへ10%パラジウム−炭素0.12
5gを懸濁させ、水素雰囲気下、水浴で冷却しながら
2.5時間撹拌した。不溶物を濾去後、エバポレーター
で濾液を濃縮し、残留物に酢酸16mlを加え、90℃
で3.5時間撹拌した。放冷後、水酸化ナトリウム水溶
液で反応液を中和し、クロロホルムで抽出した。クロロ
ホルム層を無水硫酸ナトリウムを用い脱水後、濃縮し
た。残留物をシリカゲルカラムクロマトグラフィにて精
製して(溶出溶媒:クロロホルム:メタノール=93:
7)、下記(3)式で表される化合物1.1gを得た。
LC/MSにより分子量(175)を確認した。また1
H−NMRの分析結果は次のようであった。1H−NM
R(CDCl3):δ=2.48(3H,s),2.9
9(6H,s),6.60(1H,d,J=7.3H
z),7.00−7.10(2H,m),10.44
(1H,br)。4) 2-Methyl-4- (dimethylamino)
3- (dimethylamino) obtained in 3) in a benzimidazole reaction flask
1.25 g of 2-nitroaniline in 20 ml of ethanol
Was dissolved. There 10% palladium-carbon 0.12
5 g were suspended and stirred for 2.5 hours while cooling in a water bath under a hydrogen atmosphere. After removing the insoluble matter by filtration, the filtrate was concentrated by an evaporator, and 16 ml of acetic acid was added to the residue.
For 3.5 hours. After cooling, the reaction solution was neutralized with an aqueous sodium hydroxide solution and extracted with chloroform. The chloroform layer was dehydrated using anhydrous sodium sulfate and concentrated. The residue was purified by silica gel column chromatography (elution solvent: chloroform: methanol = 93:
7), 1.1 g of a compound represented by the following formula (3) was obtained.
The molecular weight (175) was confirmed by LC / MS. Also one
H-NMR analysis results were as follows. 1H-NM
R (CDCl3): [delta] = 2.48 (3H, s), 2.9
9 (6H, s), 6.60 (1H, d, J = 7.3H)
z), 7.00-7.10 (2H, m), 10.44
(1H, br).
【0028】[0028]
【化8】 Embedded image
【0029】実施例A−2 2−トリフルオロメチル−4−(ジメチルアミノ)ベン
ズイミダゾールの合成 実施例A−1の3)と同様にして得た3−(ジメチルア
ミノ)−2−ニトロアニリン26gをエタノール400
mlに溶解しそこへ10%パラジウム−炭素2.6gを
加え懸濁させ水素雰囲気下、水浴で冷却しながら3時間
撹拌した。不溶物を濾去後、濾液を濃縮し、得られたオ
イルにトリフルオロ酢酸300mlを加え70℃で3.
5時間撹拌した。加熱を止め放冷しクロロホルムを10
00ml入れて水酸化ナトリウム水溶液でpH8まで中
和した。分液して有機層を水洗し無水硫酸ナトリウムを
用いて脱水後、有機層を濃縮した。得られた結晶をヘキ
サン−トルエン混合溶媒で再結晶して下記(4)式で表
される化合物14gを得た。この結晶の融点は96℃で
あった。LC/MSで分子量229を確認した。この化
合物の赤外吸収スペクトル(KBr)を図1に示す。ま
たNMRの分析結果は次のようであった。1H−NMR
(DMSO−d6):δ=3.17(6H,s),6.
46(1H,d,J=7.8Hz),6.98(1H,
d,J=7.8Hz),7.21(1H,t,J=8.
1Hz),13.72(1H,br)。Example A-2 Synthesis of 2-trifluoromethyl-4- (dimethylamino) benzimidazole 26 g of 3- (dimethylamino) -2-nitroaniline obtained in the same manner as in 3) of Example A-1 To ethanol 400
Then, 2.6 g of 10% palladium-carbon was added thereto, suspended, and stirred for 3 hours while cooling in a water bath under a hydrogen atmosphere. After removing the insoluble matter by filtration, the filtrate was concentrated, and 300 ml of trifluoroacetic acid was added to the obtained oil.
Stir for 5 hours. Stop heating and allow to cool.
Then, the mixture was neutralized to pH 8 with an aqueous sodium hydroxide solution. After liquid separation, the organic layer was washed with water, dehydrated using anhydrous sodium sulfate, and then the organic layer was concentrated. The obtained crystals were recrystallized with a hexane-toluene mixed solvent to obtain 14 g of a compound represented by the following formula (4). The melting point of the crystals was 96 ° C. LC / MS confirmed a molecular weight of 229. FIG. 1 shows the infrared absorption spectrum (KBr) of this compound. The NMR analysis results were as follows. 1H-NMR
(DMSO-d6): 隆 = 3.17 (6H, s), 6.
46 (1H, d, J = 7.8 Hz), 6.98 (1H, d, J = 7.8 Hz)
d, J = 7.8 Hz), 7.21 (1H, t, J = 8.
1 Hz), 13.72 (1H, br).
【0030】[0030]
【化9】 Embedded image
【0031】実施例A−3 4−(ジメチルアミノ)ベンズイミダゾールの合成 実施例A−1の3)と同様にして得た3−(ジメチルア
ミノ)−2−ニトロアニリン500mgをエタノール8
mlに溶解させた。そこへ10%パラジウム−炭素0.
05gを懸濁させ、水素雰囲気下、水浴で冷却しながら
2時間撹拌した。不溶物を濾去後、濾液を濃縮し得られ
たオイルに蟻酸8mlを加え95℃で2.5時間撹拌し
た。加熱を止め放冷し水を加え48%水酸化ナトリウム
水溶液で反応液をアルカリ性にした。そこにテトラヒド
ロフラン、酢酸エチルを加え攪拌し有機層を分取、水
洗、濃縮して下記(5)式で表される化合物0.37g
を得た。LC/MSで分子量161を確認した。Example A-3 Synthesis of 4- (dimethylamino) benzimidazole 500 mg of 3- (dimethylamino) -2-nitroaniline obtained in the same manner as in 3) of Example A-1 was added to ethanol 8
was dissolved in ml. There 10% palladium-carbon 0.1%.
The suspension was stirred for 2 hours while cooling in a water bath under a hydrogen atmosphere. After removing the insoluble matter by filtration, the filtrate was concentrated, and 8 ml of formic acid was added to the obtained oil, followed by stirring at 95 ° C for 2.5 hours. The heating was stopped, the mixture was allowed to cool, water was added, and the reaction solution was made alkaline with a 48% aqueous sodium hydroxide solution. Thereto were added tetrahydrofuran and ethyl acetate, and the mixture was stirred. The organic layer was separated, washed with water and concentrated, and 0.37 g of a compound represented by the following formula (5) was obtained.
I got LC / MS confirmed a molecular weight of 161.
【0032】[0032]
【化10】 Embedded image
【0033】実施例A−4 2−イソプロピル−4−(ジメチルアミノ)ベンズイミ
ダゾールの合成 実施例A−1の3)と同様にして得た3−(ジメチルア
ミノ)−2−ニトロアニリン1.2gをエタノール20
mlに溶解させた。そこへ10%パラジウム−炭素0.
12gを懸濁させ、水素雰囲気下、水浴で冷却しながら
2時間撹拌した。不溶物を濾去後、濾液を濃縮し得られ
たオイルにイソ酪酸20mlを加え110℃で4時間撹
拌した。加熱を止め放冷し48%水酸化ナトリウム水溶
液で反応液をアルカリ性にした。そこに水を加えて析出
した不溶分を濾去し、濾液をクロロホルムで抽出した。
クロロホルム層を水洗後、無水硫酸ナトリウムで脱水後
濃縮しタール状物質を得た。これをシリカゲルカラムク
ロマトグラフィで精製し(溶出溶媒:トルエン〜トルエ
ン:酢酸エチル=9:1)下記(6)式で表される化合
物0.3gを得た。この結晶の融点は124℃であっ
た。LC/MSで分子量203を確認した。Example A-4 Synthesis of 2-isopropyl-4- (dimethylamino) benzimidazole 1.2 g of 3- (dimethylamino) -2-nitroaniline obtained in the same manner as in 3) of Example A-1. To ethanol 20
was dissolved in ml. There 10% palladium-carbon 0.1%.
12 g were suspended and stirred for 2 hours while cooling in a water bath under a hydrogen atmosphere. After filtering off the insoluble matter, the filtrate was concentrated, and 20 ml of isobutyric acid was added to the obtained oil, followed by stirring at 110 ° C. for 4 hours. The heating was stopped, the mixture was allowed to cool, and the reaction solution was made alkaline with a 48% aqueous sodium hydroxide solution. Water was added thereto, and the precipitated insolubles were removed by filtration, and the filtrate was extracted with chloroform.
The chloroform layer was washed with water, dehydrated with anhydrous sodium sulfate, and concentrated to obtain a tar substance. This was purified by silica gel column chromatography (elution solvent: toluene to toluene: ethyl acetate = 9: 1) to obtain 0.3 g of a compound represented by the following formula (6). The melting point of the crystals was 124 ° C. LC / MS confirmed a molecular weight of 203.
【0034】[0034]
【化11】 Embedded image
【0035】実施例A−5 2−フェニル−4−(ジメチルアミノ)ベンズイミダゾ
ールの合成 3−(ジメチルアミノ)−2−ニトロアニリン1.56
gをエタノール30mlに溶かし10%パラジウム−炭
素0.20gを加え水素雰囲気下で4.8時間撹拌し
た。触媒を濾去、濾液を濃縮し得られた化合物1.70
gにポリリン酸30ml、安息香酸1.62gを加え1
70℃まで昇温し35分攪拌した後、この温度のまま安
息香酸0.19gを追加し更に、1.3時間攪拌後、加
熱を止め放冷した。反応液を水に排出し、水酸化ナトリ
ウム水溶液で中和した。しばらく攪拌した後、濾過し結
晶を水洗しメタノールで再結晶して(7)式で示される
目的物1.1gを得た。この結晶の融点は165℃であ
った。LC/MSで分子量237を確認した。NMR分
析結果は次のようであった。1H−NMR(CDCl
3):δ=3.21(6H,s),6.38(d,1
H,J=7.7Hz),6.93(d,1H,J=7.
7Hz),7.04(t,1H,J=7.9Hz),
7.42−7.55(m,3H),8.15(d,2
H,J=7.2Hz),12,61(s,1H)。13
C−NMR(CDCl3):δ=41.69,101.
48,105.05,123.30,125.91,1
28.59,128.99,130.34,134.4
6,136.16,143.32,147.37。Example A-5 Synthesis of 2-phenyl-4- (dimethylamino) benzimidazole 3- (dimethylamino) -2-nitroaniline 1.56
g was dissolved in 30 ml of ethanol, 0.20 g of 10% palladium-carbon was added, and the mixture was stirred under a hydrogen atmosphere for 4.8 hours. The catalyst was removed by filtration, and the filtrate was concentrated to give compound 1.70.
to 30 g of polyphosphoric acid and 1.62 g of benzoic acid
After the temperature was raised to 70 ° C. and the mixture was stirred for 35 minutes, 0.19 g of benzoic acid was added at this temperature, and the mixture was further stirred for 1.3 hours. The reaction solution was discharged into water and neutralized with an aqueous sodium hydroxide solution. After stirring for a while, the crystals were filtered, the crystals were washed with water, and recrystallized with methanol to obtain 1.1 g of the desired product represented by the formula (7). The melting point of the crystals was 165 ° C. LC / MS confirmed a molecular weight of 237. The NMR analysis results were as follows. 1H-NMR (CDCl
3): δ = 3.21 (6H, s), 6.38 (d, 1
H, J = 7.7 Hz), 6.93 (d, 1H, J = 7.
7 Hz), 7.04 (t, 1H, J = 7.9 Hz),
7.42-7.55 (m, 3H), 8.15 (d, 2
H, J = 7.2 Hz), 12, 61 (s, 1H). 13
C-NMR (CDCl 3): δ = 41.69, 101.
48, 105.05, 123.30, 125.91, 1
28.59, 128.99, 130.34, 134.4
6,136.16, 143.32, 147.37.
【0036】[0036]
【化12】 Embedded image
【0037】実施例A−6 2−トリフルオロメチル−4−(ピペリジノ)ベンズイ
ミダゾールの合成 1)2−ニトロ−3−ピペリジノアセトアニリド 実施例A−1の1)と同様の操作で得た2,3−ジニト
ロアセトアニリド4.7g、エタノール50mlを混
合、攪拌しながらピペリジン23mlを0.3時間かけ
て滴下し、70〜75℃に昇温して2時間撹拌した。加
熱を止め反応液を放冷し水に排出して得られた結晶を濾
取、水洗しエタノールで再結晶した。GC/MSで分子
量263を確認した。Example A-6 Synthesis of 2-trifluoromethyl-4- (piperidino) benzimidazole 1) 2-Nitro-3-piperidinoacetanilide Obtained by the same procedure as in 1) of Example A-1. 4.7 g of 2,3-dinitroacetanilide and 50 ml of ethanol were mixed, and 23 ml of piperidine was added dropwise over 0.3 hours while stirring, and the mixture was heated to 70 to 75 ° C. and stirred for 2 hours. The heating was stopped, the reaction solution was allowed to cool and discharged into water. The obtained crystals were collected by filtration, washed with water, and recrystallized with ethanol. GC / MS confirmed a molecular weight of 263.
【0038】2)2−ニトロ−3−ピペリジノアニリン 1)で得た2−ニトロ−3−ピペリジノアセトアニリド
3.4g、エタノール30mlを混合しこれに48%水
酸化ナトリウム水溶液16mlを少しずつ加え、加熱し
た。溶媒の還流温度で2.5時間撹拌した後、反応液を
放冷し、水に排出してクロロホルムで抽出した。クロロ
ホルム層を水洗、濃縮して目的物3.3gを得た。GC
/MSで分子量221を確認した。2) 2-Nitro-3-piperidinoaniline 3.4 g of 2-nitro-3-piperidinoacetanilide obtained in 1) and 30 ml of ethanol were mixed, and 16 ml of a 48% aqueous sodium hydroxide solution was slightly added thereto. And heated. After stirring at the reflux temperature of the solvent for 2.5 hours, the reaction solution was allowed to cool, discharged into water and extracted with chloroform. The chloroform layer was washed with water and concentrated to obtain 3.3 g of the desired product. GC
/ MS confirmed molecular weight 221.
【0039】3)4−ピペリジノ−2−トリフルオロメ
チルベンズイミダゾール 2)で得た2−ニトロ−3−ピペリジノアニリン2.8
g、エタノール38ml、10%パラジウム−炭素0.
28gを混合し、水素雰囲気下で室温で2時間撹拌し
た。その後系内を窒素置換し、反応液を濾過して濾液を
濃縮した。これにトリフルオロ酢酸38mlを少しずつ
加え、発熱がおさまってから昇温し還流温度で1.5時
間撹拌した。反応液を放冷し水に排出し水酸化ナトリウ
ムで中和した後、得られた結晶を濾取しエタノールから
再結晶して下記(8)式で示される目的物2.3gを得
た。LC/MSで分子量269を確認した。3) 4-Piperidino-2-trifluoromethylbenzimidazole 2-nitro-3-piperidinoaniline obtained in 2) 2.8
g, ethanol 38 ml, 10% palladium-carbon 0.
28 g were mixed and stirred at room temperature under a hydrogen atmosphere for 2 hours. Thereafter, the inside of the system was replaced with nitrogen, the reaction solution was filtered, and the filtrate was concentrated. To this was added 38 ml of trifluoroacetic acid little by little, and after the exotherm had subsided, the temperature was raised and the mixture was stirred at the reflux temperature for 1.5 hours. The reaction solution was allowed to cool, discharged into water, neutralized with sodium hydroxide, and the obtained crystals were collected by filtration and recrystallized from ethanol to obtain 2.3 g of the desired product represented by the following formula (8). LC / MS confirmed a molecular weight of 269.
【0040】[0040]
【化13】 Embedded image
【0041】実施例A−7 2−メチル−4−(ジエチルアミノ)ベンズイミダゾー
ルの合成 1)3−(ジエチルアミノ)−2−ニトロアセトアニリ
ド 実施例A−1の1)と同様の方法で得た2,3−ジニト
ロアセトアニリド1.0gをDMF6mlに溶かし、5
0℃まで昇温し、これにジエチルアミン0.65gを少
しずつ加え50〜60℃で2時間攪拌した後、更に昇温
し60〜80℃で18時間撹拌した。加熱を止め反応液
を放冷し水に排出して析出した不溶分を濾別し、濾液を
酢酸エチルで抽出した。酢酸エチル層を水洗、濃縮して
1.4gの目的物を得た。GC/MSで分子量251を
確認した。Example A-7 Synthesis of 2-methyl-4- (diethylamino) benzimidazole 1) 3- (Diethylamino) -2-nitroacetanilide 2, a compound obtained by a method similar to 1) of Example A-1 Dissolve 1.0 g of 3-dinitroacetanilide in 6 ml of DMF and add
After the temperature was raised to 0 ° C, 0.65 g of diethylamine was added little by little, and the mixture was stirred at 50 to 60 ° C for 2 hours. The heating was stopped, the reaction solution was allowed to cool, discharged into water, and the precipitated insolubles were separated by filtration. The filtrate was extracted with ethyl acetate. The ethyl acetate layer was washed with water and concentrated to obtain 1.4 g of the desired product. GC / MS confirmed a molecular weight of 251.
【0042】3)2−メチル−4−(ジエチルアミノ)
ベンズイミダゾール 2)で得た3−(ジエチルアミノ)−2−ニトロアセト
アニリド1.4gをエタノール20mlに溶解させた。
そこへ10%パラジウム−炭素0.14gを懸濁させ、
水素雰囲気下、水浴で冷却しながら3時間撹拌した。不
溶物を濾去後、エバポレーターで濾液を濃縮し、残留物
に酢酸16mlを加え、90℃で4時間撹拌した。放冷
後、水酸化ナトリウム水溶液で反応液を中和し、クロロ
ホルムで抽出した。クロロホルム層を無水硫酸ナトリウ
ムを用い脱水後、濃縮した。残留物をシリカゲルカラム
クロマトグラフィにて精製して下記(9)式で表される
化合物1.2gを得た。LC/MSにより分子量203
を確認した。3) 2-Methyl-4- (diethylamino)
1.4 g of 3- (diethylamino) -2-nitroacetanilide obtained in benzimidazole 2) was dissolved in 20 ml of ethanol.
There, 0.14 g of 10% palladium-carbon was suspended,
The mixture was stirred for 3 hours while cooling in a water bath under a hydrogen atmosphere. After removing the insoluble matter by filtration, the filtrate was concentrated with an evaporator, 16 ml of acetic acid was added to the residue, and the mixture was stirred at 90 ° C for 4 hours. After cooling, the reaction solution was neutralized with an aqueous sodium hydroxide solution and extracted with chloroform. The chloroform layer was dehydrated using anhydrous sodium sulfate and concentrated. The residue was purified by silica gel column chromatography to obtain 1.2 g of a compound represented by the following formula (9). Molecular weight 203 by LC / MS
It was confirmed.
【0043】[0043]
【0044】実施例A−8 1−エチル−2−トリフルオロメチル−4(7)−(ジ
エチルアミノ)−5,6−ジメチルベンズイミダゾール
の合成 1)5,6−ジメチル−4−ニトロ−2−トリフルオロ
メチルベンズイミダゾール 98%硫酸10mlを5℃以下に冷却し撹拌しながら、
そこに2−トリフルオロメチル−5,6−ジメチルベン
ズイミダゾール3.2gを発煙硝酸10mlに溶かした
ものを30分かけて滴下した。その後、40分撹拌した
後、反応液を氷水にあけ濾過して得られた固形分をアル
カリ水、続いて水で洗浄後、乾燥して結晶2.7gを得
た。GC/MSで分子量259を確認した。Example A-8 Synthesis of 1-ethyl-2-trifluoromethyl-4 (7)-(diethylamino) -5,6-dimethylbenzimidazole 1) 5,6-dimethyl-4-nitro-2-nitro While cooling 10 ml of trifluoromethylbenzimidazole 98% sulfuric acid to 5 ° C. or less and stirring,
A solution obtained by dissolving 3.2 g of 2-trifluoromethyl-5,6-dimethylbenzimidazole in 10 ml of fuming nitric acid was added dropwise thereto over 30 minutes. Then, after stirring for 40 minutes, the reaction solution was poured into ice water and filtered, and the obtained solid was washed with alkali water and then with water, and dried to obtain 2.7 g of crystals. A molecular weight of 259 was confirmed by GC / MS.
【0045】2)4−アミノ−5,6−ジメチル−2−
トリフルオロメチルベンズイミダゾール 上記1)でえたニトロ化合物2.7gをエタノール70
mlに仕込み撹拌しながら、10%パラジウム−炭素
1.0gを仕込み水素ガスを導入して3時間撹拌した。
反応液を濾過して濾液を濃縮、乾燥して結晶1.0gを
得た。GC/MSで分子量229を確認した。2) 4-amino-5,6-dimethyl-2-
Trifluoromethylbenzimidazole 2.7 g of the nitro compound obtained in 1) above was added to ethanol 70
While stirring and charging to 1.0 ml, 10% palladium-carbon (1.0 g) was charged and hydrogen gas was introduced and stirred for 3 hours.
The reaction solution was filtered, and the filtrate was concentrated and dried to obtain 1.0 g of crystals. A molecular weight of 229 was confirmed by GC / MS.
【0046】3)1−エチル−4(7)−(ジエチルア
ミノ)−5,6−ジメチル−2−トリフルオロメチルベ
ンズイミダゾール 上記2)でえたアミノ化合物0.23g、DMF2m
l、無水炭酸カリウム0.30gを混合、撹拌しながら
ヨウ化エチル0.34gを1時間で滴下しその後4時間
撹拌した。その後、無水炭酸カリウム0.3g、ヨウ化
エチル0.69gを追加し70℃にして3時間撹拌し
た。加熱を止め反応液にトルエンと水を加え撹拌後、ト
ルエン層を分取、濃縮して下記(10)式で示される化
合物0.36gを得た。GC/MSで分子量313を確
認した。3) 1-ethyl-4 (7)-(diethylamino) -5,6-dimethyl-2-trifluoromethylbenzimidazole 0.23 g of the amino compound obtained in the above 2), DMF2m
and 0.30 g of anhydrous potassium carbonate were mixed and stirred, and 0.34 g of ethyl iodide was added dropwise over 1 hour, followed by stirring for 4 hours. Thereafter, 0.3 g of anhydrous potassium carbonate and 0.69 g of ethyl iodide were added, and the mixture was stirred at 70 ° C. for 3 hours. The heating was stopped, toluene and water were added to the reaction solution, and the mixture was stirred. The toluene layer was separated and concentrated to obtain 0.36 g of a compound represented by the following formula (10). GC / MS confirmed a molecular weight of 313.
【0047】[0047]
【化15】 Embedded image
【0048】実施例A−9 1)4−メチル−3−ニトロアセトアニリド 反応フラスコに4−メチル−3−ニトロアニリン9.1
gとトルエン60mlを仕込み攪拌しながらそこに無水
酢酸6.7gを2時間で滴下した。その後室温で4時間
攪拌後、反応液を濾過して得られた結晶をトルエンで洗
浄し乾燥して11.2gの結晶を得た。Example A-9 1) 4-Methyl-3-nitroacetanilide A reaction flask was charged with 4-methyl-3-nitroaniline 9.1.
g and 60 ml of toluene were added and 6.7 g of acetic anhydride was added dropwise thereto over 2 hours while stirring. After stirring at room temperature for 4 hours, the reaction solution was filtered, and the obtained crystals were washed with toluene and dried to obtain 11.2 g of crystals.
【0049】2)4−メチル−2,3−ジニトロアセト
アニリド 反応フラスコに発煙硝酸16mlを仕込み撹拌しなが
ら、10〜15℃で4−メチル−3−ニトロアセトアニ
リド3.9gを1時間かけて仕込み、その後1時間撹拌
した。反応液を氷水150mlにあけしばらく撹拌した
後、濾過した。結晶をトルエンで洗浄した後、酢酸で再
結晶、乾燥して2.2gの結晶を得た。この結晶の融点
は124℃であった。GC/MSで分子量239を確認
した。2) 4-Methyl-2,3-dinitroacetanilide 16 ml of fuming nitric acid was charged into a reaction flask, and 3.9 g of 4-methyl-3-nitroacetanilide was charged at 10 to 15 ° C. over 1 hour with stirring. Thereafter, the mixture was stirred for 1 hour. The reaction solution was poured into 150 ml of ice water, stirred for a while, and then filtered. The crystals were washed with toluene, recrystallized with acetic acid and dried to obtain 2.2 g of crystals. The melting point of the crystals was 124 ° C. GC / MS confirmed a molecular weight of 239.
【0050】3)4−メチル−2−ニトロ−3−(ブチ
ルアミノ)アセトアニリド 反応フラスコに2)で得た4−メチル−2,3−ジニト
ロアセトアニリド2.2g、エタノール16ml、ブチ
ルアミン8mlを仕込み攪拌しながら60℃に昇温して
6時間攪拌後、反応液を濃縮して2.6gの目的物粗製
品を得た。GC/MSで分子量265を確認した。3) 4-Methyl-2-nitro-3- (butylamino) acetanilide A reaction flask was charged with 2.2 g of 4-methyl-2,3-dinitroacetanilide obtained in 2), 16 ml of ethanol and 8 ml of butylamine and stirred. After heating to 60 ° C. and stirring for 6 hours, the reaction solution was concentrated to obtain 2.6 g of a crude product of the target product. GC / MS confirmed a molecular weight of 265.
【0051】4)4−メチル−2−ニトロ−3−(N−
ブチル−N−ヘキシルアミノ)アセトアニリド 反応フラスコに3)で得た4−メチル−2−ニトロ−3
−(ブチルアミノ)アセトアニリド2.6g、ジメチル
ホルムアミド10ml、炭酸カリウム1.8g、1−ブ
ロモヘキサン2.2gを仕込み70〜80℃で20時間
反応した。反応液を水に排出しトルエンで抽出し抽出液
を水洗、乾燥、濃縮して2.9gの目的物粗製品を得
た。4) 4-Methyl-2-nitro-3- (N-
Butyl-N-hexylamino) acetanilide 4-Methyl-2-nitro-3 obtained in 3) was placed in a reaction flask.
2.6 g of-(butylamino) acetanilide, 10 ml of dimethylformamide, 1.8 g of potassium carbonate and 2.2 g of 1-bromohexane were charged and reacted at 70 to 80 ° C for 20 hours. The reaction solution was discharged into water, extracted with toluene, and the extract was washed with water, dried and concentrated to obtain 2.9 g of a crude product of the desired product.
【0052】5)4−メチル−2−アミノ−3−(N−
ブチル−N−ヘキシルアミノ)アニリン 反応フラスコに4)で得た4−メチル−2−ニトロ−3
−(N−ブチル−N−ヘキシルアミノ)アセトアニリド
2.9g、酢酸10ml、亜鉛末3.2gを仕込み徐々
に昇温して50℃で2時間攪拌した。反応液を放冷後、
濾過し、濾液を水酸化ナトリウム水溶液で中和した後、
トルエンで抽出した。抽出液を水洗、乾燥、濃縮して
2.5gの目的物粗製品を得た。5) 4-Methyl-2-amino-3- (N-
Butyl-N-hexylamino) aniline 4-methyl-2-nitro-3 obtained in 4) was placed in a reaction flask.
2.9 g of-(N-butyl-N-hexylamino) acetanilide, 10 ml of acetic acid, and 3.2 g of zinc dust were charged, and the mixture was gradually heated and stirred at 50 ° C for 2 hours. After allowing the reaction solution to cool,
After filtration and neutralization of the filtrate with aqueous sodium hydroxide,
Extracted with toluene. The extract was washed with water, dried and concentrated to obtain 2.5 g of a crude product of the desired product.
【0053】6)5−メチル−4−(N−ブチル−N−
ヘキシルアミノ)−2−(トリフルオロメチル)ベンズ
イミダゾール 反応フラスコに5)で得た4−メチル−2−アミノ−3
−(N−ブチル−N−ヘキシルアミノ)アニリン2.5
gを仕込みトリフルオロ酢酸30mlを加え70℃で4
時間攪拌した。加熱を止め放冷し水、クロロホルムを加
え水酸化ナトリウム水溶液で中和した。分液して有機層
を水洗、乾燥後、濃縮し、得られた目的物粗製品をカラ
ムクラマトグラフィで精製して下記(11)式で表され
る目的物0.12gを得た。LC/MSで分子量355
を確認した。6) 5-Methyl-4- (N-butyl-N-
Hexylamino) -2- (trifluoromethyl) benzimidazole 4-methyl-2-amino-3 obtained in 5) in a reaction flask
-(N-butyl-N-hexylamino) aniline 2.5
g, and 30 ml of trifluoroacetic acid was added thereto.
Stirred for hours. The heating was stopped, the mixture was allowed to cool, water and chloroform were added, and the mixture was neutralized with an aqueous sodium hydroxide solution. After liquid separation, the organic layer was washed with water, dried and concentrated. The obtained crude product of the target product was purified by column chromatography to obtain 0.12 g of the target product represented by the following formula (11). Molecular weight 355 by LC / MS
It was confirmed.
【0054】[0054]
【化16】 Embedded image
【0055】実施例A−10 4−(ピロリジノ)−2−(トリフルオロメチル)ベン
ズイミダゾールの合成 1)2,3−ジニトロアニリン 反応フラスコに実施例A−1の1)と同様にして得た
2,3−ジニトロアセトアニリド4.3g、メタノール
87ml、28%ナトリウムメチラート−メタノール溶
液3.7gを仕込み溶媒の環流温度で90分攪拌した。
その後反応液を水に排出し攪拌、濾過、得られた結晶を
水洗、乾燥して目的物3.4gを得た。GC/MSで分
子量183を確認した。Example A-10 Synthesis of 4- (pyrrolidino) -2- (trifluoromethyl) benzimidazole 1) 2,3-dinitroaniline Obtained in a reaction flask in the same manner as in 1) of Example A-1. 4.3 g of 2,3-dinitroacetanilide, 87 ml of methanol and 3.7 g of a 28% sodium methylate-methanol solution were stirred at the reflux temperature of the charged solvent for 90 minutes.
Thereafter, the reaction solution was discharged into water, stirred, filtered, and the obtained crystals were washed with water and dried to obtain 3.4 g of the desired product. GC / MS confirmed a molecular weight of 183.
【0056】2)1,2−ジニトロ−3−ピロリジノベ
ンゼン 反応フラスコに1)で得た2,3−ジニトロアニリン
3.7g、ジメチルホルムアミド20ml、無水炭酸カ
リウム6.6g、1,4−ジブロモブタン5.2gを仕
込み60〜70℃で4時間攪拌後、無水炭酸カリウム
2.0g、1,4−ジブロモブタン1.0gを追加し6
0〜70℃で3時間攪拌した。反応液を水500mlに
排出し酢酸エチル50mlで抽出し抽出液を水洗、濃縮
し得られた結晶をメタノールでほぐし濾過、乾燥して
1.5gの目的物結晶を得た。GC/MSで分子量23
7を確認した。この結晶の融点は96℃であった。2) 1,2-Dinitro-3-pyrrolidinobenzene In a reaction flask, 3.7 g of 2,3-dinitroaniline obtained in 1), 20 ml of dimethylformamide, 6.6 g of anhydrous potassium carbonate, 1,4-dibromo After charging butane (5.2 g) and stirring at 60 to 70 ° C. for 4 hours, anhydrous potassium carbonate (2.0 g) and 1,4-dibromobutane (1.0 g) were added.
Stir at 0-70 ° C for 3 hours. The reaction solution was discharged into 500 ml of water and extracted with 50 ml of ethyl acetate. The extract was washed with water, concentrated, and the obtained crystals were loosened with methanol, filtered and dried to obtain 1.5 g of crystals of the desired product. Molecular weight 23 by GC / MS
7 was confirmed. The melting point of the crystals was 96 ° C.
【0057】3)1.2−ジアミノ−3−ピロリジノベ
ンゼン 反応フラスコに2)で得た2,3−ジニトロピロリジノ
ベンゼン1.5g、エタノール30ml、10%パラジ
ウム−炭素0.15gを仕込み水素雰囲気下、5時間反
応した。不溶物を濾去後、濾液を濃縮して1.1gの目
的物粗製品を得た。3) 1.2-Diamino-3-pyrrolidinobenzene A reaction flask was charged with 1.5 g of 2,3-dinitropyrrolidinobenzene obtained in 2), 30 ml of ethanol and 0.15 g of 10% palladium-carbon, and charged with hydrogen. The reaction was performed for 5 hours under an atmosphere. After filtering off the insoluble matter, the filtrate was concentrated to obtain 1.1 g of a crude product of the desired product.
【0058】4)4−(ピロリジノ)−2−(トリフル
オロメチル)ベンズイミダゾール 反応フラスコに3)で得た1,2−ジアミノ−3−ピロ
リジノベンゼン1.1gを仕込みトリフルオロ酢酸15
mlを加え70℃で3時間攪拌した。加熱を止め放冷し
水、クロロホルムを加え水酸化ナトリウム水溶液で中和
した。分液して有機層を水洗、乾燥後、濃縮し、得られ
た目的物粗製品をカラムクラマトグラフィで精製して下
記(12)式で表される化合物0.46gを得た。LC
/MSで分子量255を確認した。4) 4- (Pyrrolidino) -2- (trifluoromethyl) benzimidazole A reaction flask was charged with 1.1 g of 1,2-diamino-3-pyrrolidinobenzene obtained in 3), and trifluoroacetic acid 15
Then, the mixture was stirred at 70 ° C. for 3 hours. The heating was stopped, the mixture was allowed to cool, water and chloroform were added, and the mixture was neutralized with an aqueous sodium hydroxide solution. After liquid separation, the organic layer was washed with water, dried and concentrated. The obtained crude product of the target was purified by column chromatography to obtain 0.46 g of a compound represented by the following formula (12). LC
/ MS confirmed a molecular weight of 255.
【0059】[0059]
【化17】 Embedded image
【0060】B.一般式(2−a)、(2−b)の化合
物の合成(これらの生成物の構造は後記表1〜表3にま
とめて示す)B. Synthesis of compounds of general formulas (2-a) and (2-b) (the structures of these products are shown in Tables 1 to 3 below)
【0061】実施例B−1 反応フラスコに実施例A−1で得た2−メチル−4−
(ジメチルアミノ)ベンズイミダゾール0.25gを仕
込みメタノール2.2ml、酢酸0.7mlに溶解させ
室温で撹拌した。そこへヨウ素0.0036gを仕込み
溶解後、2−ヒドラジノ−5−トリフルオロメチルピリ
ジン0.34gを少しずつ仕込みさらに30%過酸化水
素水0.35gを少しずつ滴下した。30分間撹拌後、
濾過して得られた結晶をメタノール−アセトン混合溶媒
中に仕込み攪拌、濾取、乾燥して目的とする7−(5−
トリフルオロメチル−2−ピリジルアゾ)−2−メチル
−4−(ジメチルアミノ)ベンズイミダゾール0.21
gを得た。LC/MSで分子量348を確認した。この
化合物はクロロホルム、アセトン、酢酸エチル、テトラ
ヒドロフラン、ジメチルホルムアミドのいずれの溶剤に
も1%以上溶解した。Example B-1 The reaction vessel was charged with 2-methyl-4- obtained in Example A-1.
0.25 g of (dimethylamino) benzimidazole was charged and dissolved in 2.2 ml of methanol and 0.7 ml of acetic acid, followed by stirring at room temperature. After charging and dissolving 0.0036 g of iodine therein, 0.34 g of 2-hydrazino-5-trifluoromethylpyridine was added little by little, and 0.35 g of 30% hydrogen peroxide solution was added dropwise little by little. After stirring for 30 minutes,
The crystals obtained by filtration are placed in a methanol-acetone mixed solvent, stirred, filtered, and dried to obtain the desired 7- (5-
Trifluoromethyl-2-pyridylazo) -2-methyl-4- (dimethylamino) benzimidazole 0.21
g was obtained. LC / MS confirmed a molecular weight of 348. This compound was dissolved in any solvent of chloroform, acetone, ethyl acetate, tetrahydrofuran and dimethylformamide in an amount of 1% or more.
【0062】実施例B−2 実施例A−1で得た2−メチル−4−(ジメチルアミ
ノ)ベンズイミダゾール0.25gをメタノール2.2
ml、酢酸0.7mlに溶解させ室温で撹拌した。そこ
へヨウ素0.0036gを仕込み溶解後、2−ヒドラジ
ノ−4,6−ジメチルピリミジン0.34gを少しずつ
仕込みさらに30%過酸化水素水0.3gを少しずつ滴
下した。1時間撹拌後、濾過して得られた結晶をメタノ
ールで洗浄、濾取して7−(4,6−ジメチル−2−ピ
リミジニルアゾ)−2−メチル−4−(ジメチルアミ
ノ)ベンズイミダゾール0.21gを得た。この化合物
はクロロホルム、アセトン、酢酸エチル、テトラヒドロ
フラン、ジメチルホルムアミドのいずれの溶剤にも1%
以上溶解した。Example B-2 0.25 g of 2-methyl-4- (dimethylamino) benzimidazole obtained in Example A-1 was added to methanol 2.2.
and 0.7 ml of acetic acid and stirred at room temperature. After charging and dissolving 0.0036 g of iodine therein, 0.34 g of 2-hydrazino-4,6-dimethylpyrimidine was added little by little, and 0.3 g of 30% hydrogen peroxide solution was added dropwise little by little. After stirring for 1 hour, the crystals obtained by filtration are washed with methanol, collected by filtration, and filtered to give 7- (4,6-dimethyl-2-pyrimidinylazo) -2-methyl-4- (dimethylamino) benzimidazole. 21 g were obtained. This compound is 1% in any solvent such as chloroform, acetone, ethyl acetate, tetrahydrofuran and dimethylformamide.
The above was dissolved.
【0063】実施例B−3 反応フラスコに実施例A−1で得た2−メチル−4−
(ジメチルアミノ)ベンズイミダゾール250mg、メ
タノール2.2ml、酢酸0.7mlを仕込み室温で撹
拌しながらヨウ素3.6mgを仕込み、溶解したら4−
ヒドラジノ−6−メチル−2−フェニルピリミジン34
3mgを少しずつ仕込み、さらに30%過酸化水素水
0.35gを滴下した。10分間撹拌した後濾過。得ら
れた結晶をメタノール−アセトン混合溶媒で洗浄、乾燥
して、7−(6−メチル−2−フェニル−4−ピリミジ
ニルアゾ)−2−メチル−4−(ジメチルアミノ)ベン
ズイミダゾール0.21gを得た。LC/MSで分子量
372を確認した。Example B-3 The 2-methyl-4- obtained in Example A-1 was placed in a reaction flask.
(Dimethylamino) benzimidazole (250 mg), methanol (2.2 ml), and acetic acid (0.7 ml) were charged, and while stirring at room temperature, iodine (3.6 mg) was charged.
Hydrazino-6-methyl-2-phenylpyrimidine 34
3 mg was added little by little, and further 0.35 g of 30% aqueous hydrogen peroxide was added dropwise. After stirring for 10 minutes, the mixture was filtered. The obtained crystals were washed with a methanol-acetone mixed solvent and dried to obtain 0.21 g of 7- (6-methyl-2-phenyl-4-pyrimidinylazo) -2-methyl-4- (dimethylamino) benzimidazole. Obtained. LC / MS confirmed molecular weight 372.
【0064】実施例B−4 2−アミノチアゾール0.143g、62%硫酸0.5
7g、水1.57gを混合し撹拌しながら氷浴で0℃ま
で冷却した(A成分)。一方、2−メチル−4−(ジメ
チルアミノ)ベンズイミダゾール0.20g、メタノー
ル6.2ml、酢酸ナトリウム0.26g、尿素0.0
26gを混合し撹拌しながら氷浴で0℃まで冷却した
(B成分)。次に亜硝酸ナトリウム0.1g、62%硫
酸0.11g、水2.0gを混合したものをA成分中に
滴下し、5分間撹拌した反応液をB成分に滴下し30分
撹拌した。反応混合物を濾過して得られた結晶を水に溶
解させ、飽和炭酸水素ナトリウム水溶液で中和して析出
した結晶を濾取、乾燥して、7−(2−チアゾリルア
ゾ)−2−メチル−4−(ジメチルアミノ)ベンズイミ
ダゾール56mgを得た。Example B-4 0.143 g of 2-aminothiazole, 0.5% of 62% sulfuric acid
7 g and 1.57 g of water were mixed and cooled to 0 ° C. in an ice bath with stirring (component A). On the other hand, 0.20 g of 2-methyl-4- (dimethylamino) benzimidazole, 6.2 ml of methanol, 0.26 g of sodium acetate, 0.02 g of urea
26 g were mixed and cooled to 0 ° C. in an ice bath with stirring (component B). Next, a mixture of 0.1 g of sodium nitrite, 0.11 g of 62% sulfuric acid, and 2.0 g of water was dropped into the component A, and the reaction solution stirred for 5 minutes was dropped into the component B, followed by stirring for 30 minutes. The crystals obtained by filtering the reaction mixture are dissolved in water, neutralized with a saturated aqueous solution of sodium hydrogen carbonate, and the precipitated crystals are collected by filtration, dried and dried to give 7- (2-thiazolylazo) -2-methyl-4. 56 mg of-(dimethylamino) benzimidazole were obtained.
【0065】実施例B−5 実施例A−2で得た2−トリフルオロメチル−4−(ジ
メチルアミノ)ベンズイミダゾール1.5gをメタノー
ル10ml、酢酸3mlに溶解させ室温で撹拌した。そ
こへヨウ素0.03gを仕込み、溶解後2−ヒドラジノ
−5−トリフルオロメチルピリジン1.4gを少しずつ
仕込み、さらに30%過酸化水素水2.0gを滴下し
た。1時間撹拌後反応液を濾過して得られた結晶を熱湯
で洗浄し、さらにメタノール−酢酸エチル混合溶媒で再
結晶して7−(5−トリフルオロメチル−2−ピリジル
アゾ)−2−トリフルオロメチル−4−(ジメチルアミ
ノ)ベンズイミダゾール1.4gを得た。LC/MSで
分子量402を確認した。NMRの分析結果は次のよう
であった。1H−NMR(CDCl3):δ=3.77
(6H,s),6.66(1H,d,J=9.5H
z),7.51(1H,d,J=9.5Hz),7.7
4(1H,d,J=8.7Hz),7.94(1H,d
dd,J=0.5Hz),8.71−8.72(1H,
m)。元素分析値はH=2.90%、C=47.85
%、N=20.88%、F=28.18%であった(理
論値H=3.01%、C=47.77%、N=20.8
9%、F=28.34%)。この化合物の赤外吸収スペ
クトル(KBr)、可視吸収スペクトル(クロロホル
ム)を図2、図3にそれぞれ示す。Example B-5 1.5 g of 2-trifluoromethyl-4- (dimethylamino) benzimidazole obtained in Example A-2 was dissolved in 10 ml of methanol and 3 ml of acetic acid and stirred at room temperature. 0.03 g of iodine was added thereto, and after dissolution, 1.4 g of 2-hydrazino-5-trifluoromethylpyridine was added little by little, and 2.0 g of 30% hydrogen peroxide solution was further added dropwise. After stirring for 1 hour, the reaction solution was filtered, and the resulting crystals were washed with hot water and recrystallized with a mixed solvent of methanol and ethyl acetate to give 7- (5-trifluoromethyl-2-pyridylazo) -2-trifluoro. 1.4 g of methyl-4- (dimethylamino) benzimidazole were obtained. LC / MS confirmed molecular weight 402. The results of NMR analysis were as follows. 1H-NMR (CDCl3): δ = 3.77
(6H, s), 6.66 (1H, d, J = 9.5H)
z), 7.51 (1H, d, J = 9.5 Hz), 7.7
4 (1H, d, J = 8.7 Hz), 7.94 (1H, d
dd, J = 0.5 Hz), 8.71-8.72 (1H,
m). Elemental analysis: H = 2.90%, C = 47.85.
%, N = 20.88%, F = 28.18% (theoretical values H = 3.01%, C = 47.77%, N = 20.8
9%, F = 28.34%). The infrared absorption spectrum (KBr) and the visible absorption spectrum (chloroform) of this compound are shown in FIGS. 2 and 3, respectively.
【0066】実施例B−6 実施例B−5の2−ヒドラジノ−5−トリフルオロメチ
ルピリジンに代えて同モル数の4−ヒドラジノ−6−メ
チル−2−フェニルピリミジンを用い、他は実施例B−
5と同様に操作して後記表1のNo.6のアゾ色素を得
た。Example B-6 The same moles of 4-hydrazino-6-methyl-2-phenylpyrimidine were used in place of 2-hydrazino-5-trifluoromethylpyridine in Example B-5, except that B-
No. 5 in Table 1 below by operating in the same manner as No. 5. Thus, 6 azo dyes were obtained.
【0067】実施例B−7 実施例B−5の2−ヒドラジノ−5−トリフルオロメチ
ルピリジンに代えて同モル数の2−ヒドラジノ−4,6
−ジメチルピリミジンを用い、他は実施例B−5と同様
に操作して後記表1のNo.7のアゾ色素を得た。Example B-7 The same molar number of 2-hydrazino-4,6 was used in place of 2-hydrazino-5-trifluoromethylpyridine of Example B-5.
-Dimethylpyrimidine was used, and the other procedures were the same as in Example B-5. 7 azo dyes were obtained.
【0068】実施例B−8 実施例B−5の2−ヒドラジノ−5−トリフルオロメチ
ルピリジンに代えて同モル数の3−ヒドラジノ−6−フ
ェニルピリダジンを用い、他は実施例B−5と同様に操
作して後記表1のNo.8のアゾ色素を得た。Example B-8 The same molar number of 3-hydrazino-6-phenylpyridazine was used in place of 2-hydrazino-5-trifluoromethylpyridine of Example B-5, and the others were the same as Example B-5. The same operation was performed in the same manner as in Table 1 below. Thus, 8 azo dyes were obtained.
【0069】実施例B−9 実施例B−5の2−ヒドラジノ−5−トリフルオロメチ
ルピリジンに代えて同モル数の4−ヒドラジノ−6−ト
リフルオロメチルピリミジンを用い、他は実施例B−5
と同様に操作して後記表1のNo.9のアゾ色素を得
た。Example B-9 The same molar number of 4-hydrazino-6-trifluoromethylpyrimidine was used in place of 2-hydrazino-5-trifluoromethylpyridine in Example B-5, except that 5
No. in Table 1 described below. 9 azo dyes were obtained.
【0070】実施例B−10 実施例B−4の2−アミノチアゾールの代わりに同モル
数の2−アミノチアジアゾールを、2−メチル−4−
(ジメチルアミノ)ベンズイミダゾールの代わりに同モ
ル数の2−トリフルオロメチル−4−(ジメチルアミ
ノ)ベンズイミダゾールを用い、他は実施例B−4と同
様に操作して後記表1のNo.10のアゾ色素を得た。Example B-10 In place of 2-aminothiazole of Example B-4, the same molar number of 2-aminothiadiazole was used instead of 2-methyl-4-
The same molar number of 2-trifluoromethyl-4- (dimethylamino) benzimidazole was used in place of (dimethylamino) benzimidazole, and the others were operated in the same manner as in Example B-4. 10 azo dyes were obtained.
【0071】実施例B−11 3−アミノイソキサゾール0.03g、62%硫酸0.
04ml、酢酸0.39ml、プロピオン酸0.2ml
を混合し撹拌、氷浴で0℃まで冷却。そこへ44%ニト
ロシル硫酸0.04mlを加え撹拌した(A成分)。一
方、2−メチル−4−(ジメチルアミノ)ベンズイミダ
ゾール90mg、メタノール1.2ml、尿素0.00
9g、酢酸ナトリウム0.09gを混合し撹拌、氷浴で
0℃まで冷却した(B成分)。A成分をB成分に滴下、
撹拌した。析出した結晶を濾取、水洗、メタノール洗
浄、乾燥して後記表1のNo.11の化合物90mgを
得た。Example B-11 0.03 g of 3-aminoisoxazole, 0.2% of 62% sulfuric acid.
04 ml, acetic acid 0.39 ml, propionic acid 0.2 ml
And stirred and cooled to 0 ° C. in an ice bath. Thereto, 0.04 ml of 44% nitrosylsulfuric acid was added and stirred (component A). On the other hand, 2-methyl-4- (dimethylamino) benzimidazole 90 mg, methanol 1.2 ml, urea 0.00
9 g and 0.09 g of sodium acetate were mixed, stirred, and cooled to 0 ° C. in an ice bath (component (B)). A component is dropped on B component,
Stirred. The precipitated crystals were collected by filtration, washed with water, washed with methanol, and dried. 90 mg of 11 were obtained.
【0072】実施例B−12 実施例B−5の2−ヒドラジノ−5−トリフルオロメチ
ルピリジンに代えて同モル数の2−ヒドラジノキノリン
を用い、他は実施例B−5と同様に操作して後記表1の
No.12のアゾ色素を得た。Example B-12 The same procedure as in Example B-5 was repeated, except that the same molar number of 2-hydrazinoquinoline was used instead of 2-hydrazino-5-trifluoromethylpyridine in Example B-5. No. in Table 1 below. Twelve azo dyes were obtained.
【0073】実施例B−13 実施例B−5の2−ヒドラジノ−5−トリフルオロメチ
ルピリジンに代えて同モル数の2−ヒドラジノピリミジ
ンを用い、他は実施例B−5と同様に操作して後記表2
のNo.13のアゾ色素を得た。Example B-13 The same procedure as in Example B-5 was followed, except that the same molar number of 2-hydrazinopyrimidine was used instead of 2-hydrazino-5-trifluoromethylpyridine in Example B-5. Table 2 below
No. 13 azo dyes were obtained.
【0074】実施例B−14 実施例B−5の2−ヒドラジノ−5−トリフルオロメチ
ルピリジンに代えて同モル数の4−ヒドラジノ−2−メ
チル−6−フェニルピリミジンを用い、他は実施例B−
5と同様に操作して後記表2のNo.14のアゾ色素を
得た。Example B-14 The same procedure as in Example B-5 was repeated except that 2-hydrazino-5-trifluoromethylpyridine was replaced with the same molar number of 4-hydrazino-2-methyl-6-phenylpyrimidine. B-
No. 5 in Table 2 described below by operating in the same manner as No. 5. 14 azo dyes were obtained.
【0075】実施例B−15 2−アミノ−3,5−ジクロロピリジン83mg、20
%ナトリウムエチラート−エタノール溶液173mg、
エタノール1mlを仕込み撹拌しながら亜硝酸イソペン
チル60mgを滴下した後、加熱して還流温度で1時間
撹拌した。そこに実施例A−2で得た2−トリフルオロ
メチル−4−(ジメチルアミノ)ベンズイミダゾール6
0mgを加え2時間撹拌した。加熱を止め放冷し水を加
えて析出した結晶を濾取し、メタノールで洗浄後、乾燥
した。後記表2のNo.15のアゾ色素32mgを得
た。Example B-15 2-amino-3,5-dichloropyridine 83 mg, 20 mg
% Sodium ethylate-ethanol solution 173 mg,
After 1 ml of ethanol was charged and 60 mg of isopentyl nitrite was added dropwise with stirring, the mixture was heated and stirred at the reflux temperature for 1 hour. There, 2-trifluoromethyl-4- (dimethylamino) benzimidazole 6 obtained in Example A-2 was used.
0 mg was added and the mixture was stirred for 2 hours. The heating was stopped, the mixture was allowed to cool, water was added, and the precipitated crystals were collected by filtration, washed with methanol, and dried. No. of Table 2 below. 32 mg of 15 azo dyes were obtained.
【0076】実施例B−16 実施例B−10の2−アミノチアゾールに代えて、同モ
ル数の3−アミノ−1,2,4−トリアゾールを用い他
は実施例B−10と同様に操作して後記表1のNo.1
6のアゾ色素を得た。Example B-16 The same procedure as in Example B-10 was repeated, except that the same molar number of 3-amino-1,2,4-triazole was used instead of 2-aminothiazole in Example B-10. No. in Table 1 below. 1
Thus, 6 azo dyes were obtained.
【0077】実施例B−17 実施例B−16で得たアゾ色素50mg、N,N−ジメ
チルホルムアミド1ml、無水炭酸カリウム15mg、
ヨウ化プロピル16mgを混合し30〜40℃で5時間
撹拌した後、加熱を止め放冷し、水を加えて析出した結
晶を濾取、乾燥して後記表2のNo.17のアゾ色素を
得た。Example B-17 50 mg of the azo dye obtained in Example B-16, 1 ml of N, N-dimethylformamide, 15 mg of anhydrous potassium carbonate,
After mixing 16 mg of propyl iodide and stirring at 30 to 40 ° C. for 5 hours, heating was stopped and the mixture was allowed to cool. Water was added, and the precipitated crystals were collected by filtration, dried, and dried. 17 azo dyes were obtained.
【0078】実施例B−18 実施例B−4の2−アミノチアゾールに代えて同モル数
の3−アミノ−5−メチルピラゾールを用い、他は実施
例B−4と同様に操作して後記表2のNo.18のアゾ
色素を得た。Example B-18 The same procedure as in Example B-4 was followed except that the same molar number of 3-amino-5-methylpyrazole was used in place of 2-aminothiazole in Example B-4, and the following description was used. No. of Table 2 18 azo dyes were obtained.
【0079】実施例B−19 実施例B−18で得たアゾ色素50mg、N,N−ジメ
チルホルムアミド1ml、無水炭酸カリウム15mg、
ヨウ化プロピル17mgを混合し30〜40℃で5時間
撹拌した後、加熱を止め放冷し、水を加えて析出した結
晶を濾取、乾燥して後記表2のNo.19のアゾ色素を
得た。Example B-19 50 mg of the azo dye obtained in Example B-18, 1 ml of N, N-dimethylformamide, 15 mg of anhydrous potassium carbonate,
After mixing 17 mg of propyl iodide and stirring at 30 to 40 ° C. for 5 hours, heating was stopped and the mixture was allowed to cool. Water was added, and the precipitated crystals were collected by filtration, dried, and dried. 19 azo dyes were obtained.
【0080】実施例B−20 実施例B−5の2−ヒドラジノ−5−トリフルオロメチ
ルピリジンに代えて同モル数の2−ヒドラジノ−3,6
−ジメチルピラジンを用い、他は実施例B−5と同様に
操作して後記表2のNo.20のアゾ色素を得た。Example B-20 The same molar number of 2-hydrazino-3,6 was used in place of 2-hydrazino-5-trifluoromethylpyridine of Example B-5.
-Dimethylpyrazine was used, and otherwise operated in the same manner as in Example B-5. 20 azo dyes were obtained.
【0081】実施例B−21 実施例B−4の2−メチル−4−(ジメチルアミノ)ベ
ンズイミダゾールに代えて実施例A−2で得た2−トリ
フルオロメチル−4−(ジメチルアミノ)ベンズイミダ
ゾールを同モル数用い、他は実施例B−4と同様に操作
して後記表2のNo.21のアゾ色素を得た。Example B-21 2-trifluoromethyl-4- (dimethylamino) benz obtained in Example A-2 in place of 2-methyl-4- (dimethylamino) benzimidazole of Example B-4 The same molar number of imidazole was used, and the other procedures were the same as in Example B-4, and the results were as shown in Table 2 below. 21 azo dyes were obtained.
【0082】実施例B−22 実施例B−5の2−ヒドラジノ−5−トリフルオロメチ
ルピリジンに代えて同モル数の2−ヒドラジノ−4−メ
チルピリジンを用い、他は実施例B−5と同様に操作し
て後記表2のNo.22のアゾ色素を得た。Example B-22 The same molar number of 2-hydrazino-4-methylpyridine was used in place of 2-hydrazino-5-trifluoromethylpyridine of Example B-5, except that Example B-5 was the same as Example B-5. By operating in the same manner as in No. 2 in Table 2 below. Thus, 22 azo dyes were obtained.
【0083】実施例B−23 実施例B−5の2−ヒドラジノ−5−トリフルオロメチ
ルピリジンに代えて同モル数の2−ヒドラジノピリジン
を用い、他は実施例B−5と同様に操作して後記表2の
No.23のアゾ色素を得た。Example B-23 The same procedure as in Example B-5 was followed, except that the same molar number of 2-hydrazinopyridine was used instead of 2-hydrazino-5-trifluoromethylpyridine in Example B-5. No. in Table 2 below. 23 azo dyes were obtained.
【0084】実施例B−24 実施例B−5の2−ヒドラジノ−5−トリフルオロメチ
ルピリジンに代えて同モル数の2−ヒドラジノ−4,6
−ジフェニルピリミジンを用い、他は実施例B−5と同
様に操作して後記表2のNo.24のアゾ色素を得た。Example B-24 The same molar number of 2-hydrazino-4,6 was used in place of 2-hydrazino-5-trifluoromethylpyridine of Example B-5.
-Diphenylpyrimidine was used, and the other procedures were the same as in Example B-5. 24 azo dyes were obtained.
【0085】実施例B−25 実施例B−5の2−ヒドラジノ−5−トリフルオロメチ
ルピリジンに代えて同モル数の2−ヒドラジノベンゾチ
アゾールを用い、他は実施例B−5と同様に操作して後
記表3のNo.25のアゾ色素を得た。Example B-25 The same procedure as in Example B-5 was repeated, except that the same molar number of 2-hydrazinobenzothiazole was used in place of the 2-hydrazino-5-trifluoromethylpyridine of Example B-5. Operate No. 3 in Table 3 below. 25 azo dyes were obtained.
【0086】実施例B−26 実施例B−1の2−メチル−4−(ジメチルアミノ)ベ
ンズイミダゾールに代えて実施例A−4で得た2−イソ
プロピル−4−(ジメチルアミノ)ベンズイミダゾール
を同モル数用い、他は実施例B−1と同様に操作して後
記表3のNo.26のアゾ色素を得た。Example B-26 2-isopropyl-4- (dimethylamino) benzimidazole obtained in Example A-4 was replaced with 2-methyl-4- (dimethylamino) benzimidazole in Example B-1. The same molar number was used, and the other procedures were the same as in Example B-1. 26 azo dyes were obtained.
【0087】実施例B−27 実施例B−26の2−ヒドラジノ−5−トリフルオロメ
チルピリジンに代えて同モル数の4−ヒドラジノ−6−
メチル−2−フェニルピリミジンを用い、他は実施例B
−26と同様に操作して後記表3のNo.27のアゾ色
素を得た。Example B-27 The same molar number of 4-hydrazino-6 was used in place of 2-hydrazino-5-trifluoromethylpyridine of Example B-26.
Example B using methyl-2-phenylpyrimidine and others
No. 26 in Table 3 described below. 27 azo dyes were obtained.
【0088】実施例B−28 実施例B−27の2−イソプロピル−4−(ジメチルア
ミノ)ベンズイミダゾールに代えて実施例A−3で得た
4−(ジメチルアミノ)ベンズイミダゾールを同モル数
用い、他は実施例B−27と同様に操作して後記表3の
No.28のアゾ色素を得た。Example B-28 The same molar number of 4- (dimethylamino) benzimidazole obtained in Example A-3 was used instead of 2-isopropyl-4- (dimethylamino) benzimidazole in Example B-27. And the others were operated in the same manner as in Example B-27. 28 azo dyes were obtained.
【0089】実施例B−29 実施例B−5の2−トリフルオロメチル−4−(ジメチ
ルアミノ)ベンズイミダゾールに代えて実施例A−3で
得た4−(ジメチルアミノ)ベンズイミダゾールを同モ
ル数用い、他は実施例B−5と同様に操作して後記表3
のNo.29のアゾ色素を得た。Example B-29 Instead of 2-trifluoromethyl-4- (dimethylamino) benzimidazole of Example B-5, 4- (dimethylamino) benzimidazole obtained in Example A-3 was equimolar. Using the same numbers as in Example B-5, operate as in Example B-5.
No. 29 azo dyes were obtained.
【0090】実施例B−30 実施例B−5の2−トリフルオロメチル−4−(ジメチ
ルアミノ)ベンズイミダゾールに代えて実施例A−6で
得た2−トリフルオロメチル−4−ピペリジノベンズイ
ミダゾールを同モル数用い、他は実施例B−5と同様に
操作して後記表3のNo.30のアゾ色素を得た。Example B-30 2-trifluoromethyl-4-piperidino obtained in Example A-6 in place of 2-trifluoromethyl-4- (dimethylamino) benzimidazole of Example B-5 The same molar number of benzimidazole was used, except that the operation was the same as in Example B-5. 30 azo dyes were obtained.
【0091】実施例B−31 実施例B−5の2−トリフルオロメチル−4−(ジメチ
ルアミノ)ベンズイミダゾールに代えて実施例A−7で
得た2−トリフルオロメチル−4−(ジエチルアミノ)
ベンズイミダゾールを同モル数用い、他は実施例B−5
と同様に操作して後記表3のNo.31のアゾ色素を得
た。Example B-31 2-trifluoromethyl-4- (diethylamino) obtained in Example A-7 in place of 2-trifluoromethyl-4- (dimethylamino) benzimidazole of Example B-5
The same moles of benzimidazole were used and the others were as in Example B-5.
No. in Table 3 described below. 31 azo dyes were obtained.
【0092】実施例B−32 実施例B−30の2−ヒドラジノ−5−トリフルオロメ
チルピリジンに代えて同モル数の4−ヒドラジノ−6−
メチル−2−フェニルピリミジンを用い、他は実施例B
−30と同様に操作して後記表3のNo.32のアゾ色
素を得た。Example B-32 The same molar number of 4-hydrazino-6 was used in place of 2-hydrazino-5-trifluoromethylpyridine of Example B-30.
Example B using methyl-2-phenylpyrimidine and others
No. -30 in Table 3 below by operating in the same manner as No.-30. 32 azo dyes were obtained.
【0093】実施例B−33 実施例B−5の2−トリフルオロメチル−4−(ジメチ
ルアミノ)ベンズイミダゾールに代えて実施例A−5で
得た2−フェニル−4−(ジメチルアミノ)ベンズイミ
ダゾールを同モル数用い、他は実施例B−5と同様に操
作して後記表3のNo.33のアゾ色素を得た。Example B-33 2-phenyl-4- (dimethylamino) benz obtained in Example A-5 in place of 2-trifluoromethyl-4- (dimethylamino) benzimidazole in Example B-5 The same molar number of imidazole was used, and the other procedures were the same as in Example B-5, and the results were as shown in Table 3 below. 33 azo dyes were obtained.
【0094】実施例B−34 実施例B−5の2−ヒドラジノ−5−トリフルオロメチ
ルピリジンに代えて同モル数の4−ヒドラジノ−6−メ
トキシ−2−メチル−5−トリフルオロメチルピリミジ
ンを用い、他は実施例B−5と同様に操作して後記表3
のNo.34のアゾ色素を得た。Example B-34 The same molar number of 4-hydrazino-6-methoxy-2-methyl-5-trifluoromethylpyrimidine was used in place of 2-hydrazino-5-trifluoromethylpyridine in Example B-5. Using the same procedures as in Example B-5 but following Table 3
No. 34 azo dyes were obtained.
【0095】実施例B−35 実施例B−4の2−アミノチアゾールの代わりに同モル
数の4−アミノ−5−シアノ−1−フェニルイミダゾー
ルを、2−メチル−4−(ジメチルアミノ)ベンズイミ
ダゾールの代わりに同モル数の2−トリフルオロメチル
−4−(ジメチルアミノ)ベンズイミダゾールを用い、
他は実施例B−4と同様に操作して後記表3のNo.3
5のアゾ色素を得た。Example B-35 Instead of 2-aminothiazole of Example B-4, the same molar number of 4-amino-5-cyano-1-phenylimidazole was used instead of 2-methyl-4- (dimethylamino) benz. Using the same molar number of 2-trifluoromethyl-4- (dimethylamino) benzimidazole instead of imidazole,
Others were operated in the same manner as in Example B-4, and No. 3 in Table 3 below. 3
Thus, 5 azo dyes were obtained.
【0096】[0096]
【表1】 [Table 1]
【0097】[0097]
【表2】 [Table 2]
【0098】[0098]
【表3】 [Table 3]
【0099】以上の表1〜表3に掲げた化合物の代表例
について溶液中での極大吸収波長(λmax)を下記表
4に示す。Table 4 below shows the maximum absorption wavelength (λmax) in the solution for the representative examples of the compounds shown in Tables 1 to 3 above.
【0100】[0100]
【表4】 [Table 4]
【0101】C.金属キレート化合物の合成 実施例C−1 実施例B−5で得た7−(5−トリフルオロメチル−2
−ピリジルアゾ)−2−トリフルオロメチル−4−(ジ
メチルアミノ)ベンズイミダゾール1.1gをメタノー
ル15ml中に懸濁させ、撹拌しながら50℃まで加熱
しそこへ酢酸ニッケル四水和物0.33gを少しずつ加
えた。そのまま2時間加熱攪拌した後、放冷して濾過し
た。得られた結晶を熱水で洗浄、乾燥して下記(13)
式で表されるニッケル錯体1.0gを得た。LC/MS
で分子量861を確認した。元素分析値はH=2.49
%、C=44.70%、N=19.62%、F=26.
78%であった(理論値はH=2.57%、C=44.
63%、N=19.52%、F=26.47%)。この
化合物の赤外吸収スペクトル(KBr)、可視吸収スペ
クトル(クロロホルム)を図4、図5にそれぞれ示す。C. Synthesis of metal chelate compound Example C-1 7- (5-trifluoromethyl-2) obtained in Example B-5
-Pyridylazo) -2-trifluoromethyl-4- (dimethylamino) benzimidazole (1.1 g) was suspended in methanol (15 ml) and heated to 50 ° C. while stirring, and nickel acetate tetrahydrate (0.33 g) was added thereto. Added little by little. After heating and stirring for 2 hours as it was, the mixture was allowed to cool and filtered. The obtained crystals are washed with hot water and dried to obtain the following (13)
1.0 g of a nickel complex represented by the formula was obtained. LC / MS
The molecular weight of 861 was confirmed. Elemental analysis: H = 2.49.
%, C = 44.70%, N = 19.62%, F = 26.
78% (theoretical values H = 2.57%, C = 44.
63%, N = 19.52%, F = 26.47%). The infrared absorption spectrum (KBr) and the visible absorption spectrum (chloroform) of this compound are shown in FIGS. 4 and 5, respectively.
【0102】[0102]
【化18】 Embedded image
【0103】この化合物はクロロホルム、アセトン、酢
酸エチル、テトラヒドロフラン、ジメチルホルムアミド
のいずれの溶剤にも1%以上溶解した。また、光ディス
ク用色素の塗布溶剤としてよく使われる2,2,3,3
−テトラフルオロプロパノール、2,2,3,3,4,
4,5,5−オクタフルオロペンタノールのいずれにも
1%以上溶解した。またクロロホルム中での吸収極大波
長(λmax)は612nm、同波長におけるモル吸光
係数εは130000であった。またこの結晶の示差熱
走査熱量分析(DSC)における補外発熱開始温度は3
16℃、発熱ピーク温度は322℃、発熱量が94J/
g、熱重量分析(TGA)における補外減量開始温度は
335℃、500℃までの重量減少率は44%であっ
た。なお、これらDSC、TGAの分析はいずれも、窒
素雰囲気下、昇温速度10℃/minで測定したもので
あり、以下の例においても同様である。This compound was dissolved in a solvent of 1% or more in any of chloroform, acetone, ethyl acetate, tetrahydrofuran and dimethylformamide. In addition, 2,2,3,3 which is often used as a coating solvent for dyes
-Tetrafluoropropanol, 2,2,3,3,4
1% or more was dissolved in any of 4,5,5-octafluoropentanol. The maximum absorption wavelength (λmax) in chloroform was 612 nm, and the molar extinction coefficient ε at the same wavelength was 130,000. The extrapolated heat generation temperature of this crystal in differential thermal scanning calorimetry (DSC) was 3
16 ° C, exothermic peak temperature 322 ° C, calorific value 94 J /
g. The starting temperature of extrapolation weight loss by thermogravimetric analysis (TGA) was 335 ° C, and the weight loss rate up to 500 ° C was 44%. Note that these DSC and TGA analyzes were performed at a rate of temperature increase of 10 ° C./min in a nitrogen atmosphere, and the same applies to the following examples.
【0104】実施例C−2 実施例B−3で得た7−(2−フェニル−6−メチル−
4−ピリミジニルアゾ)−2−メチル−4−(ジメチル
アミノ)ベンズイミダゾール100mgをメタノール
1.5ml中に懸濁させ撹拌しながら50℃まで加熱し
た。そこへ酢酸ニッケル四水和物34mgを少しずつ加
えた。そのまま30分間加熱攪拌した後、放冷して濾過
した。得られた結晶を熱湯、メタノールで洗浄後、乾燥
して目的とするニッケル錯体83mgを得た。LC/M
Sで分子量800を確認した。この結晶のDSCにおけ
る補外発熱開始温度は349℃、発熱ピーク温度は35
2℃、発熱量が107J/g、TGAにおける補外減量
開始温度は368℃、500℃までの重量減少率は53
%であった。Example C-2 7- (2-Phenyl-6-methyl) obtained in Example B-3
100 mg of 4-pyrimidinylazo) -2-methyl-4- (dimethylamino) benzimidazole was suspended in 1.5 ml of methanol and heated to 50 ° C with stirring. 34 mg of nickel acetate tetrahydrate was added thereto little by little. After heating and stirring as such for 30 minutes, the mixture was allowed to cool and filtered. The obtained crystals were washed with hot water and methanol and then dried to obtain 83 mg of the desired nickel complex. LC / M
S confirmed the molecular weight of 800. The extrapolated heat generation temperature by DSC of this crystal was 349 ° C., and the heat generation peak temperature was 35.
2 ° C., calorific value is 107 J / g, extrapolation weight loss starting temperature in TGA is 368 ° C., weight loss rate up to 500 ° C. is 53
%Met.
【0105】実施例C−3 実施例C−1の酢酸ニッケル四水和物に代えて同モル数
の酢酸亜鉛二水和物を用い、他は実施例C−1と同様に
操作して目的とする亜鉛錯体を得た。LC/MSにより
分子量867を確認した。NMRの分析結果は次のよう
であった。1H−NMR(CDCl3):δ=3.79
(12H,br),6.69(2H,d,J=9.5H
z),7.75(2H,d,J=9.5Hz),7.7
8(2H,dd,J=9.0Hz),7.93(2H,
d,J=9.0Hz),8.02−8.03(1H,
m)Example C-3 The same procedure as in Example C-1 was repeated, except that the same molar number of zinc acetate dihydrate was used in place of the nickel acetate tetrahydrate of Example C-1. Was obtained. A molecular weight of 867 was confirmed by LC / MS. The results of NMR analysis were as follows. 1H-NMR (CDCl3): δ = 3.79
(12H, br), 6.69 (2H, d, J = 9.5H)
z), 7.75 (2H, d, J = 9.5 Hz), 7.7
8 (2H, dd, J = 9.0 Hz), 7.93 (2H,
d, J = 9.0 Hz), 8.02-8.03 (1H,
m)
【0106】実施例C−4 実施例C−1の酢酸ニッケル四水和物に代えて同モル数
の酢酸銅無水物を用い、他は実施例C−1と同様に操作
して目的とする銅錯体を得た。この結晶のDSCにおけ
る補外発熱開始温度は239℃、発熱ピーク温度は26
0℃、発熱量は404J/g、TGAにおける補外減量
開始温度は268℃、500℃までの重量減少率は39
%であった。Example C-4 The same procedure as in Example C-1 was repeated, except that the same moles of copper acetate anhydride were used in place of the nickel acetate tetrahydrate of Example C-1. A copper complex was obtained. The extrapolated heat generation start temperature in DSC of this crystal was 239 ° C., and the heat generation peak temperature was 26.
0 ° C., calorific value is 404 J / g, extrapolation weight loss starting temperature in TGA is 268 ° C., and weight loss rate up to 500 ° C. is 39
%Met.
【0107】実施例C−5 実施例C−1の酢酸ニッケル四水和物に代えて同モル数
の酢酸マンガン四水和物を用い、他は実施例C−1と同
様に操作して目的とするマンガン錯体を得た。Example C-5 The same procedure as in Example C-1 was repeated, except that the same molar number of manganese acetate tetrahydrate was used in place of the nickel acetate tetrahydrate of Example C-1. Was obtained.
【0108】実施例C−6 実施例C−1の酢酸ニッケル四水和物に代えて同モル数
の塩化アルミニウム六水和物とナトリウムメチラートを
用い、他は実施例C−1と同様に操作して目的とするア
ルミニウム錯体を得た。Example C-6 The same moles of aluminum chloride hexahydrate and sodium methylate were used in place of the nickel acetate tetrahydrate of Example C-1, and the other conditions were the same as in Example C-1. The desired aluminum complex was obtained by operation.
【0109】実施例C−7〜C−39 実施例C−1と同様の方法で、下記表5及び表6に示す
アゾ化合物と金属イオンとを反応させて金属キレート錯
体を得た。表5及び表6で示すアゾ化合物の化合物番号
は表1〜表4の化合物番号と共通する。また表5及び表
6では生成した金属錯体色素の溶液中でのλmaxも示
している。Examples C-7 to C-39 In the same manner as in Example C-1, azo compounds shown in Tables 5 and 6 below were reacted with metal ions to obtain metal chelate complexes. The compound numbers of the azo compounds shown in Tables 5 and 6 are common to the compound numbers in Tables 1 to 4. Tables 5 and 6 also show λmax in solution of the produced metal complex dye.
【0110】[0110]
【表5】 [Table 5]
【0111】[0111]
【表6】 [Table 6]
【0112】D.耐光性試験 上記の実施例で得た化合物につき次のような方法で耐光
性試験を行った。 実施例D−1 前記実施例C−1で得た含金属アゾ色素0.5g、10
%ポリビニルアルコール水溶液10g、水7.0gを混
合し、ガラスビーズ20gを加え、ペイントシェーカー
で30分振とうして色素を粉砕し水層に分散させた。こ
の分散液を中性紙の上にワイヤーバーを使い塗布し、風
乾して、色素塗布量が0.6g/m2である塗布紙を得
た。塗布面の色相は紫色であった。D. Light fastness test The compounds obtained in the above examples were subjected to a light fastness test by the following method. Example D-1 0.5 g of the metal-containing azo dye obtained in Example C-1
10 g of a 10% aqueous solution of polyvinyl alcohol and 7.0 g of water were mixed, and 20 g of glass beads were added. This dispersion was applied onto neutral paper using a wire bar and air-dried to obtain a coated paper having a dye coating amount of 0.6 g / m2. The hue of the coated surface was purple.
【0113】比較例 上記実施例D−1における含金属アゾ色素の代わりに下
記(14)式で表される色素を同量用い、他は実施例D
−1と同様に操作して色素塗布紙を得た。塗布面の色相
は青紫色であった。Comparative Example In place of the metal-containing azo dye in Example D-1, the same amount of the dye represented by the following formula (14) was used.
-1 to obtain a dye-coated paper. The hue of the coated surface was bluish purple.
【0114】[0114]
【化19】 Embedded image
【0115】上記実施例D−1及び比較例で得た色素塗
布紙をカーボンアークを光源とするフェードテスターで
24時間露光して、露光前後の吸光度を測定した。その
結果を下記表7に示す。The dye-coated papers obtained in Example D-1 and Comparative Example were exposed for 24 hours with a fade tester using a carbon arc as a light source, and the absorbance before and after the exposure was measured. The results are shown in Table 7 below.
【0116】[0116]
【表7】 [Table 7]
【0117】以上の実施例から、本発明のベンズイミダ
ゾール化合物から導かれるアゾ化合物、含金属アゾ化合
物が様々な吸収波長を持ちうる吸光係数の高い色素であ
り、有機溶剤に対する溶解度も良く、耐光性も良好であ
ることが確認された。なお、以上の実施例の化合物を分
析するにあたっては下記の分析装置を使用した。 GC/MS:株式会社島津製作所製GCMS−QP20
00GF LC/MS:同社製LCMS−QP8000 IR :同社製FTIR−8000PC DSC :同社製DSC−50 TGA :同社製TGA−50 NMR :日本電子株式会社製FT−NMRスペクト
ロメーターΛ300 可視吸収スペクトル(溶液) :株式会社島津製作所製
UV−2500PC 可視吸収スペクトル(固体膜):株式会社島津製作所製
UV−365From the above examples, the azo compounds and metal-containing azo compounds derived from the benzimidazole compounds of the present invention are dyes having a high absorption coefficient that can have various absorption wavelengths, have good solubility in organic solvents, and have good light resistance. Was also confirmed to be good. In analyzing the compounds of the above examples, the following analyzer was used. GC / MS: GCMS-QP20 manufactured by Shimadzu Corporation
00GF LC / MS: Company's LCMS-QP8000 IR: Company's FTIR-8000PC DSC: Company's DSC-50 TGA: Company's TGA-50 NMR: JEOL FT-NMR spectrometer # 300 Visible absorption spectrum (solution) : UV-2500PC made by Shimadzu Corporation Visible absorption spectrum (solid film): UV-365 made by Shimadzu Corporation
【0118】[0118]
【発明の効果】本発明は、各種の色素合成の中間物とし
て有用なベンズイミダゾール化合物を提供するものであ
り、それを用いて合成されるアゾ色素及びその金属キレ
ート色素は、高溶解性、高耐光性などの優れた性質を有
しており、産業上、利用価値の高いものである。The present invention provides a benzimidazole compound useful as an intermediate in the synthesis of various dyes. An azo dye and a metal chelate dye synthesized using the benzimidazole compound have high solubility and high solubility. It has excellent properties such as light resistance, and is of high industrial value.
【図1】実施例A−2で得た化合物の赤外吸収スペクト
ルFIG. 1 is an infrared absorption spectrum of the compound obtained in Example A-2.
【図2】実施例B−5で得た化合物の赤外吸収スペクト
ルFIG. 2 is an infrared absorption spectrum of the compound obtained in Example B-5.
【図3】実施例B−5で得た化合物の可視吸収スペクト
ルFIG. 3 is a visible absorption spectrum of the compound obtained in Example B-5.
【図4】実施例C−1で得た化合物の赤外吸収スペクト
ルFIG. 4 is an infrared absorption spectrum of the compound obtained in Example C-1.
【図5】実施例C−1で得た化合物の可視吸収スペクト
ル FIG. 5 is a visible absorption spectrum of the compound obtained in Example C-1.
───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.7 識別記号 FI テーマコート゛(参考) C09B 29/09 C09B 29/09 B C Z 45/00 45/00 (72)発明者 谷口 正俊 京都市南区上鳥羽上調子町1番地1 山田 化学工業株式会社内 Fターム(参考) 4C063 AA01 BB09 CC26 CC29 CC34 CC43 CC51 CC62 DD12 DD14 DD22 DD26 ──────────────────────────────────────────────────の Continued on the front page (51) Int.Cl. 7 Identification symbol FI Theme coat ゛ (Reference) C09B 29/09 C09B 29/09 BC Z 45/00 45/00 (72) Inventor Masatoshi Taniguchi Minami Kyoto City 1F, Kamidaba-Kamichocho-ku, Yamada F-term in Yamada Chemical Industry Co., Ltd. 4C063 AA01 BB09 CC26 CC29 CC34 CC43 CC51 CC62 DD12 DD14 DD22 DD26
Claims (7)
表されるベンズイミダゾール化合物。 【化1】 [式中、R1、R2は水素原子、アルキル基、アルコキ
シアルキル基、シアノアルキル基、アリールアルキル
基、アリール基を表す。R1とR2は同時に水素原子に
はならない。R1とR2はこれらが結合している窒素原
子と複素環を形成していてもよい。R3は水素原子、ア
ルキル基、フッ化アルキル基、置換または非置換のアリ
ール基を表す。R4は水素原子、置換または非置換のア
ルキル基、置換または非置換のアリール基を表す。R
5、R6は水素原子、アルキル基、フッ化アルキル基、
アルコキシ基、ハロゲン原子を表す]。1. A benzimidazole compound represented by the following general formula (1-a) or (1-b). Embedded image [Wherein, R1 and R2 represent a hydrogen atom, an alkyl group, an alkoxyalkyl group, a cyanoalkyl group, an arylalkyl group, or an aryl group. R1 and R2 do not simultaneously become hydrogen atoms. R1 and R2 may form a heterocyclic ring with the nitrogen atom to which they are bonded. R3 represents a hydrogen atom, an alkyl group, a fluorinated alkyl group, or a substituted or unsubstituted aryl group. R4 represents a hydrogen atom, a substituted or unsubstituted alkyl group, or a substituted or unsubstituted aryl group. R
5, R6 is a hydrogen atom, an alkyl group, a fluorinated alkyl group,
Represents an alkoxy group or a halogen atom].
2とがこれらに結合している窒素原子とピロリジン環も
しくはピペリジン環を形成するものであり、R3が水素
原子、フッ素原子で置換されていてもよい低級アルキル
基、未置換のフェニル基であり、R4、R5、R6が水
素原子、低級アルキル基である請求項1記載のベンズイ
ミダゾール化合物。2. R1 and R2 are alkyl groups, or R1 and R2
2 forms a pyrrolidine ring or a piperidine ring with the nitrogen atom bonded thereto, and R3 is a hydrogen atom, a lower alkyl group which may be substituted with a fluorine atom, or an unsubstituted phenyl group; The benzimidazole compound according to claim 1, wherein R4, R5, and R6 are a hydrogen atom or a lower alkyl group.
表されるアゾベンズイミダゾール化合物。 【化2】 [式中、R1、R2は水素原子、アルキル基、アルコキ
シアルキル基、シアノアルキル基、アリールアルキル
基、アリール基を表す。R1とR2は同時に水素原子に
はならない。R1とR2は連結して複素環を形成しても
よい。R3は水素原子、アルキル基、フッ化アルキル
基、置換基を有していてもよいアリール基を表す。R4
は水素原子、置換または非置換のアルキル基、置換また
は非置換のアリール基を表す。R5、R6は水素原子、
アルキル基、フッ化アルキル基、アルコキシ基、ハロゲ
ン原子を表す。Xは置換または非置換の芳香環、置換ま
たは非置換の複素環を表す]。3. An azobenzimidazole compound represented by the following general formula (2-a) or (2-b). Embedded image [Wherein, R1 and R2 represent a hydrogen atom, an alkyl group, an alkoxyalkyl group, a cyanoalkyl group, an arylalkyl group, or an aryl group. R1 and R2 do not simultaneously become hydrogen atoms. R1 and R2 may combine to form a heterocyclic ring. R3 represents a hydrogen atom, an alkyl group, a fluorinated alkyl group, or an optionally substituted aryl group. R4
Represents a hydrogen atom, a substituted or unsubstituted alkyl group, or a substituted or unsubstituted aryl group. R5 and R6 are hydrogen atoms,
Represents an alkyl group, a fluorinated alkyl group, an alkoxy group, or a halogen atom. X represents a substituted or unsubstituted aromatic ring or a substituted or unsubstituted heterocyclic ring].
とR2とがこれらに結合している窒素原子とピロリジン
環を形成するものであり、R3が水素原子、フッ素原子
で置換されていてもよい低級アルキル基、未置換のフェ
ニル基であり、R4、R5、R6が水素原子、低級アル
キル基であり、Xが置換および非置換のピリジン環、置
換および非置換のピリミジン環、置換および非置換のピ
リダジン環、置換および非置換のピラジン環、置換およ
び非置換のキノリン環、置換および非置換のイミダゾー
ル環、置換および非置換のピラゾール環、置換および非
置換のチアゾール環、置換および非置換のチアジアゾー
ル環、置換および非置換のオキサゾール環、置換および
非置換のイソキサゾール環、置換および非置換のトリア
ゾール環、及び置換および非置換のベンゾチアゾール環
から選ばれる複素環であって、この複素環が置換基を有
するものである場合、置換基がメチル基、トリフルオロ
メチル基、塩素原子及びフェニル基から成る群から選択
されたものである請求項3記載のアゾベンズイミダゾー
ル化合物。4. R1 and R2 are lower alkyl groups, or R1
And R2 form a pyrrolidine ring with the nitrogen atom bonded thereto, and R3 is a hydrogen atom, a lower alkyl group which may be substituted by a fluorine atom, an unsubstituted phenyl group, and R4, R5 and R6 each represent a hydrogen atom or a lower alkyl group, and X represents a substituted or unsubstituted pyridine ring, a substituted or unsubstituted pyrimidine ring, a substituted or unsubstituted pyridazine ring, a substituted or unsubstituted pyrazine ring, a substituted or unsubstituted pyrazine ring. Substituted quinoline ring, substituted and unsubstituted imidazole ring, substituted and unsubstituted pyrazole ring, substituted and unsubstituted thiazole ring, substituted and unsubstituted thiadiazole ring, substituted and unsubstituted oxazole ring, substituted and unsubstituted A heterocyclic ring selected from an isoxazole ring, a substituted and unsubstituted triazole ring, and a substituted and unsubstituted benzothiazole ring The azobenz according to claim 3, wherein, when the heterocyclic ring has a substituent, the substituent is selected from the group consisting of a methyl group, a trifluoromethyl group, a chlorine atom and a phenyl group. Imidazole compounds.
のアゾベンズイミダゾール化合物と2価金属イオンとの
キレート化合物。5. A chelate compound of the azobenzimidazole compound according to claim 3 and a divalent metal ion.
のアゾベンズイミダゾール化合物と3価金属イオンとの
キレート化合物。6. A chelate compound of the azobenzimidazole compound according to claim 3 and a trivalent metal ion.
びマンガンのいずれかである請求項5記載のキレート化
合物。7. The chelate compound according to claim 5, wherein the divalent metal ion is any of nickel, copper, zinc and manganese.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2001188869A JP4730574B2 (en) | 2001-05-18 | 2001-05-18 | Benzimidazole compounds, azobenzimidazole compounds and their chelate compounds |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2001188869A JP4730574B2 (en) | 2001-05-18 | 2001-05-18 | Benzimidazole compounds, azobenzimidazole compounds and their chelate compounds |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2002338549A true JP2002338549A (en) | 2002-11-27 |
JP4730574B2 JP4730574B2 (en) | 2011-07-20 |
Family
ID=19027878
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2001188869A Expired - Fee Related JP4730574B2 (en) | 2001-05-18 | 2001-05-18 | Benzimidazole compounds, azobenzimidazole compounds and their chelate compounds |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP4730574B2 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1306131A3 (en) * | 2001-10-23 | 2004-05-19 | Sumitomo Chemical Company, Limited | Cross-Coupling catalyst comprising a cyclic nitrogen ligand and process using the same |
US7078149B2 (en) * | 2002-06-12 | 2006-07-18 | Ritek Corporation | Optical recording medium and method for making the same |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3901910A (en) * | 1973-02-20 | 1975-08-26 | United States Borax Chem | 5-trifluoromethyl-7-aminobenzimidazoles |
JPS5823664A (en) * | 1981-04-24 | 1983-02-12 | デラランデ・エス・エ− | Novel n-aromatic group heterocyclic group substituted piperidine, piperazine and homopiperazine derivatives, manufacture and drugs |
JPS63122675A (en) * | 1986-10-27 | 1988-05-26 | アクチエボラゲツト・ヘツスレ | Novel benzimidazole derivative active as antitumor agent |
JPH07310022A (en) * | 1994-04-26 | 1995-11-28 | Ciba Geigy Ag | Cationic or basic aminobenzo-thiazole dye |
US5541229A (en) * | 1989-04-08 | 1996-07-30 | Dr. Karl Thomae Gmbh | Benzimidazoles and medicaments containing these compounds |
JPH1086519A (en) * | 1996-09-11 | 1998-04-07 | Ricoh Co Ltd | Optical recording medium |
WO1998037072A1 (en) * | 1997-02-25 | 1998-08-27 | The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services | Substituted benzimidazoles as non-nucleoside inhibitors of reverse transcriptase |
JP2000190641A (en) * | 1998-12-29 | 2000-07-11 | Tdk Corp | Optical recording medium |
-
2001
- 2001-05-18 JP JP2001188869A patent/JP4730574B2/en not_active Expired - Fee Related
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3901910A (en) * | 1973-02-20 | 1975-08-26 | United States Borax Chem | 5-trifluoromethyl-7-aminobenzimidazoles |
JPS5823664A (en) * | 1981-04-24 | 1983-02-12 | デラランデ・エス・エ− | Novel n-aromatic group heterocyclic group substituted piperidine, piperazine and homopiperazine derivatives, manufacture and drugs |
JPS63122675A (en) * | 1986-10-27 | 1988-05-26 | アクチエボラゲツト・ヘツスレ | Novel benzimidazole derivative active as antitumor agent |
US5541229A (en) * | 1989-04-08 | 1996-07-30 | Dr. Karl Thomae Gmbh | Benzimidazoles and medicaments containing these compounds |
JPH07310022A (en) * | 1994-04-26 | 1995-11-28 | Ciba Geigy Ag | Cationic or basic aminobenzo-thiazole dye |
JPH1086519A (en) * | 1996-09-11 | 1998-04-07 | Ricoh Co Ltd | Optical recording medium |
WO1998037072A1 (en) * | 1997-02-25 | 1998-08-27 | The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services | Substituted benzimidazoles as non-nucleoside inhibitors of reverse transcriptase |
JP2000190641A (en) * | 1998-12-29 | 2000-07-11 | Tdk Corp | Optical recording medium |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1306131A3 (en) * | 2001-10-23 | 2004-05-19 | Sumitomo Chemical Company, Limited | Cross-Coupling catalyst comprising a cyclic nitrogen ligand and process using the same |
US7078149B2 (en) * | 2002-06-12 | 2006-07-18 | Ritek Corporation | Optical recording medium and method for making the same |
Also Published As
Publication number | Publication date |
---|---|
JP4730574B2 (en) | 2011-07-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5244369B2 (en) | Method for producing 5-aminopyrazole derivative, azo dye | |
JPS595625B2 (en) | Azomethine | |
US3978040A (en) | Process for the preparation of cyanoazo compounds by reacting halogenoazo compounds with CuCN in an aqueous media in the presence of a nitrogen base | |
JPH0619036B2 (en) | A new synthetic method for pyrazole dyes. | |
Rabbani et al. | Novel edaravone-based azo dyes: efficient synthesis, characterization, antibacterial activity, DFT calculations and comprehensive investigation of the solvent effect on the absorption spectra | |
Zhao et al. | Increased pH stability via functional group transformation from acidic hydroxyl to basic secondary amine for a series of pyridone based heterocyclic dyes | |
JPS5845468B2 (en) | Thiazole | |
JP4730574B2 (en) | Benzimidazole compounds, azobenzimidazole compounds and their chelate compounds | |
JPS5850261B2 (en) | Azometinganriyou no seizouhouhou | |
TW201109390A (en) | Phthalocyanine compound and method for producing the same, and coloring composition containing the phthalocyanine compound | |
JPS6221023B2 (en) | ||
JP2538997B2 (en) | Process for producing diazo and azo compounds | |
JPH0764988B2 (en) | Azo dye manufacturing method | |
Heravi et al. | Heterocyclic monoazo dyes derived from 2-(p-aminophenyl) oxazolo-[4, 5-b] pyridine and 7-(p-aminophenyl)-4H-[1, 3, 4] thiadiazolo-[2, 3-c][1, 2, 4] triazin-4-one | |
EP1984454B1 (en) | Method of manufacturing a phthalocyanine compound | |
JPH1036692A (en) | Azo compound, its production, chelate metal complex comprising the azo compound, and its production | |
López-Alvarado et al. | A general synthesis of quinoline-2, 5, 8 (1H)-triones via acylation of 2, 5-dimethoxyaniline with S-tert-butyl thioacetates by application of the Knorr cyclization | |
Tagdiwala et al. | The synthesis of fused and pendant pyrazole heterocyclic compounds from 5‐amino‐3‐methyl‐1‐phenylpyrazole and their evaluation as fluorescent brightening agents | |
US4025510A (en) | 2,4-Diaryl[1,3,4H]thiadiazines fused to quinoxalines | |
JP6763213B2 (en) | New azo compound | |
CA2467511A1 (en) | Process for the preparation of 4-methyl-7-aminoquinolones | |
JP2007016203A (en) | Phthalocyanine compound, process for producing the same and colored composition containing the phthalocyanine compound | |
JP2003335974A (en) | Bipyrrolinonylidene-based compound, coloring matter containing the compound, and method for producing bipyrrolinonylidene-based compound | |
JPH0791479B2 (en) | Azo dye | |
JPS5828297B2 (en) | Azoshiki Sonoseihou |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20080326 |
|
RD02 | Notification of acceptance of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7422 Effective date: 20080326 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20101215 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20110104 |
|
A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20110224 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20110315 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20110406 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20140428 Year of fee payment: 3 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 4730574 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
LAPS | Cancellation because of no payment of annual fees |